KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
CV Kol pour Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: Statistiques d'influence
Rapport d'exécution
| Concept | World rank |
|---|---|
| association farm contact | #1 |
| increased prevalence cough | #1 |
| 5–13‐year school children | #1 |
| menarche hormonal | #1 |
| associations hscrp values | #1 |
| south bavarian population | #1 |
| concomitant bhr 95 | #1 |
| initial cohort pattern | #1 |
| prediction farm children | #1 |
| amish hutterite children | #1 |
| pasture lukas2 | #1 |
| cde source | #1 |
| male saline solution | #1 |
| study rural environment | #1 |
| children automobiles child | #1 |
| farm studies | #1 |
| igg1 galactosylation levels | #1 |
| mice atopic sensitization | #1 |
| development allergic illnesses | #1 |
| farm cowsheds | #1 |
| cla content plasma | #1 |
| cd4cd25hi tcells | #1 |
| countries pasture study | #1 |
| domestic child child | #1 |
| dresden munich | #1 |
| wheezing 3rd year | #1 |
| work overload work | #1 |
| farm dwellings homes | #1 |
| current asthma soot | #1 |
| higher hscrp values | #1 |
| bacterial exposures | #1 |
| association atopic sensitization | #1 |
| arabinogalactan cde | #1 |
| transient wheeze asthma | #1 |
| farmers nonfarmers children | #1 |
| exposure gstm1 deficiency | #1 |
| countries isaac phase | #1 |
| no2 traffic counts | #1 |
| interaction npsr1 protein | #1 |
| ema protective farm | #1 |
| tcells foxp3 | #1 |
| foxp3 demethylation tregs | #1 |
| bronchial hyperreactivity age | #1 |
| acrossolar study | #1 |
| expiratory volume lca | #1 |
| atopy allergen specificity | #1 |
| pasture study spt | #1 |
| asthma symptoms adulthood | #1 |
| asthma genetic effects | #1 |
| bifidobacterium breastfed infants | #1 |
| gabriel advanced study | #1 |
| fpr2 clec4e | #1 |
| peptidoglycan ppg birth | #1 |
| predictor igg1 galactosylation | #1 |
| amish environment | #1 |
| observing children | #1 |
| 7 yrs determinants | #1 |
| birth tbx21 | #1 |
| atopic smokers baseline | #1 |
| school age early | #1 |
| menarche hormonal contraceptives | #1 |
| wheeze farming exposure | #1 |
| incidence indoor allergens | #1 |
| covariates potential confounding | #1 |
| allergyprotective potential | #1 |
| edta tubes countries | #1 |
| predominant obstruction | #1 |
| sige association | #1 |
| increased atp2a3 fpr2 | #1 |
| maternal farming | #1 |
| maternal farming activities | #1 |
| asthma risk pasture | #1 |
| neonatal immune mechanisms | #1 |
| dermatitis symptoms | #1 |
| asthma consumption | #1 |
| pasture study tubes | #1 |
| study questionnaire responses | #1 |
| farming environment protective | #1 |
| allergies atopic dermatitis | #1 |
| german peers | #1 |
| farming children | #1 |
| jia domestic arthritis | #1 |
| role th2 immunity | #1 |
| groups rural areas | #1 |
| latent classes populations | #1 |
| antibiotics allergies | #1 |
| asthmatic farm children | #1 |
| protective 6 years | #1 |
| lca clinical phenotypes | #1 |
| leipzig munich | #1 |
| children isaac asthma | #1 |
| asthma atopic disease | #1 |
| stepwise procedure risk | #1 |
| farm environments farms | #1 |
| fever farm | #1 |
| respiratory sounds immunity | #1 |
| alliance asthma | #1 |
| determinants airway responsiveness | #1 |
| model bronchial hyperreactivity | #1 |
| gabriel advanced surveys | #1 |
| associations airwayrelated symptoms | #1 |
| th2related genes cytokines | #1 |
| new onset wheeze | #1 |
| crude measure exposure | #1 |
| farming environment development | #1 |
| yogurt diversity | #1 |
| prevalence environmental factors | #1 |
| atopic dermatitis farm | #1 |
| snps wheeze | #1 |
| package functionality | #1 |
| atopic disease bias | #1 |
| igein | #1 |
| solids relation | #1 |
| farm specific exposures | #1 |
| occupational disinfectants asthma | #1 |
| non‐farm children | #1 |
| increased risk rhinoconjunctivitis | #1 |
| barns farm dwellings | #1 |
| rural allergy endotoxin | #1 |
| influential factors phenotype | #1 |
| psychosocial characteristics asthma | #1 |
| farm indoor | #1 |
| allergic diseases hrqol | #1 |
| visible mold homes | #1 |
| ilcs neonatal mice | #1 |
| kitchen visible mold | #1 |
| males pierced ears | #1 |
| insight asthma | #1 |
| tobit regression ranks | #1 |
| npsr1 tnc | #1 |
| associations dna fingerprinting | #1 |
| score total quantity | #1 |
| atopic dermatitis onset | #1 |
| skin tests spt | #1 |
| genetic association tnc | #1 |
| diversity protective effects | #1 |
| children diabimmune study | #1 |
| aetiology atopic disease | #1 |
| lps foxp3 demethylation | #1 |
| asthma turkish | #1 |
| asthma rora | #1 |
| asthmatics innate leukocytes | #1 |
| environmental differences finland | #1 |
| lower prevalence asthma | #1 |
| 26 farms bavaria | #1 |
| classical definitions lca | #1 |
| soot benzene | #1 |
| association farm | #1 |
| transient wheezing age | #1 |
| sensitised children wheeze | #1 |
| factor school behavior | #1 |
| association incident rhinoconjunctivitis | #1 |
| asthma concomitant bhr | #1 |
| environments pasture | #1 |
| 95 asthma | #1 |
| richness asthma | #1 |
| early life insight | #1 |
| aa ifih1 expression | #1 |
| atopy microbial influences | #1 |
| farm environments asthma | #1 |
| atopic sensitization aor | #1 |
| factors th1 | #1 |
| allergic rhinitis menarche | #1 |
| farms farm homes | #1 |
| fever blood samples | #1 |
| persistence bronchial hyperreactivity | #1 |
| children indoor mould | #1 |
| logistic models npsr1 | #1 |
| farm children hrqol | #1 |
| immune stimulation life | #1 |
| gsdma expression secretion | #1 |
| 3 mm spt | #1 |
| munich leipzig | #1 |
| grass arabinogalactan mice | #1 |
| quantitative confirmation associations | #1 |
| stepwise protocol bhr | #1 |
| coding region il4ra | #1 |
| homes farm dwellings | #1 |
| risk tcell phenotypes | #1 |
| agents reduced risk | #1 |
| year environmental exposures | #1 |
| girls late onset | #1 |
| allergic diseases questionnaires | #1 |
| hlx1 snps cbmcs | #1 |
| exposure farming environment | #1 |
| gasdermin gsdma | #1 |
| allergies | #1 |
| grass arabinogalactan | #1 |
| wheeze bronchial | #1 |
| protective effects exposure | #1 |
| cutoff 3 mm | #1 |
| environmental exposure age | #1 |
| 1133 children | #1 |
| allergies respiratory infections | #1 |
| protective asthma | #1 |
| regulatory responses protection | #1 |
| farming environment role | #1 |
| overweight marked differences | #1 |
| ormdl3 gsdma expression | #1 |
| development childhood asthma | #1 |
| parental questionnaires | #1 |
| 95 puberty | #1 |
| age bacterial endotoxin | #1 |
| feeding patterns risk | #1 |
| east germany allergic | #1 |
| regression approach order | #1 |
| rs7164773 | #1 |
| mrna expression year | #1 |
| prenatal farm | #1 |
| prenatal animal | #1 |
| muramic acid wheezing | #1 |
| spt atopic dermatitis | #1 |
| transcription factors hlx1 | #1 |
| bronchial hyperreactivity wheezing | #1 |
| persistence allergic rhinitis | #1 |
| rural children w12 | #1 |
| treg marker genes | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| protection childhood asthma | #1 |
| tenascin neuropeptide receptor | #1 |
| positive sensitization | #1 |
| persistence adolescence | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| cd4cd25hi isolated cells | #1 |
| living farm | #1 |
| pierced ears association | #1 |
| asthmatics hc | #1 |
| children rural allergy | #1 |
| allergen exposure age | #1 |
| allergoprotective | #1 |
| food sensitization egg | #1 |
| hypopharynx moraxella | #1 |
| bmi allergic dermatitis | #1 |
| farm living | #1 |
| asthmaprotective farm | #1 |
| children atopic sensitization | #1 |
| fever milk consumption | #1 |
| polymorphisms tbx21 | #1 |
| work overload followup | #1 |
| development preschool wheezing | #1 |
| health services exposure | #1 |
| changing gender ratio | #1 |
| failure☆ | #1 |
| studies microbial exposures | #1 |
| fever atopic sensitization | #1 |
| wheezing invertedu shape | #1 |
| crohns disease atopy | #1 |
| wheezing fever | #1 |
| igg4 coexpression | #1 |
| inhaled steroids dresden | #1 |
| asthma diversity | #1 |
| cowsheds peak | #1 |
| sensitisation early | #1 |
| mold immune responsiveness | #1 |
| transient wheeze age | #1 |
| newborn leukocytes surveys | #1 |
| ranks performance | #1 |
| overweight munich | #1 |
| sige sensitizations symptoms | #1 |
| 95 atopic eczema | #1 |
| solar study | #1 |
| secretion life | #1 |
| actinomycetes alpine farms | #1 |
| risk mite sensitization | #1 |
| epigenetic regulation mechanism | #1 |
| asthma toll | #1 |
| rnastabilizing solution | #1 |
| 105 years richness | #1 |
| doctor allergic rhinitis | #1 |
| personal cleanliness risk | #1 |
| associations transient sensitization | #1 |
| gene expression ilt3 | #1 |
| juvenile crohn disease | #1 |
| genetic interaction npsr1 | #1 |
| participants solar | #1 |
| ddhay fever 95 | #1 |
| atopic sensitization early | #1 |
| igg4 ige expression | #1 |
| ilt4 cb | #1 |
| 1314 newborn infants | #1 |
| introduction yogurt | #1 |
| health urbanrural differences | #1 |
| environmental factors sensitization | #1 |
| order covariates | #1 |
| aa immunity receptors | #1 |
| agreement spts | #1 |
| stimulation 45yearold children | #1 |
| wheeze environmental determinants | #1 |
| 6 types cheese | #1 |
| atopic sensitisation fever | #1 |
| moisture mold exposure | #1 |
| helminth parasites exposure | #1 |
| tregs foxp3 demethylation | #1 |
| farm milk meat | #1 |
| 420lys | #1 |
| prehireonset | #1 |
| animal contact infancy | #1 |
| netcomi | #1 |
| dermatitis depending | #1 |
| farm fever | #1 |
| preventive measures counselling | #1 |
| selfreported nickel allergy | #1 |
| menarche allergic | #1 |
| allergen exposure life | #1 |
| coupled receptor polymorphisms | #1 |
| asthma puberty | #1 |
| 1120 children | #1 |
| regular farm animal | #1 |
| cleanliness dust parameters | #1 |
| spink5 kazal type | #1 |
| interaction rora | #1 |
| helminths protective | #1 |
| 18 95 incidence | #1 |
| asthma asthma bacteria | #1 |
| farming environments asthma | #1 |
| age asthma child | #1 |
| anthropometric data overweight | #1 |
| food diversity year | #1 |
| rhinoconjunctivitis participation | #1 |
| ilcs administration | #1 |
| microbial exposure sum | #1 |
| phase isaac programme | #1 |
| indoor bacterial microbiota | #1 |
| parsifal‐study | #1 |
| life protective | #1 |
| allergies topic surveys | #1 |
| th2 th1 gsdma | #1 |
| children preschool conjunctivitis | #1 |
| carriers hlx1 | #1 |
| asthma microbiome analysis | #1 |
| spink5 420lys | #1 |
| germany prevalence differences | #1 |
| innate immunity receptors | #1 |
| increased food diversity | #1 |
| traditional farms | #1 |
| isaac phase data | #1 |
| alpine farms | #1 |
| review hygiene hypothesis | #1 |
| network construction netcomi | #1 |
| nct02496468 | #1 |
| germany allergic | #1 |
| farm exposure exposure | #1 |
| environmental exposures protection | #1 |
| usage preventive measures | #1 |
| prognosis early wheeze | #1 |
| 17q21 risk | #1 |
| allergic sensitization latex | #1 |
| prehireonset odds ratio | #1 |
| lpastimulation | #1 |
| t1432c | #1 |
| pasture cohort lca | #1 |
| wholeto | #1 |
| loft farm milk | #1 |
| ahr acinetobacter lwoffii | #1 |
| environmental exposures asthma | #1 |
| preschool children predictor | #1 |
| tnc npsr1 | #1 |
| living area risk | #1 |
| questionnaires childhood | #1 |
| tbx21 | #1 |
| isolated cd4cd25hi tregs | #1 |
| phenotypes atopic sensitization | #1 |
| allergy symptoms childhood | #1 |
| sod3 sod3 snps | #1 |
| crp early age | #1 |
| ige levels exposure | #1 |
| fever atopic dermatitis | #1 |
| igg1 galactosylation predictor | #1 |
| incident wheezing association | #1 |
| aa nonallergic asthma | #1 |
| 95 hormonal contraceptives | #1 |
| microbial exposure endotoxin | #1 |
| microbial exposure patterns | #1 |
| anthroposophic lifestyle features | #1 |
| agriculture asthma | #1 |
| allergic allergic dermatitis | #1 |
| data netcomi | #1 |
| association occupational disinfectants | #1 |
| marked differences prevalence | #1 |
| tubes rnastabilizing solution | #1 |
| immune responses birth | #1 |
| adolescent agriculture dust | #1 |
| cough soot | #1 |
| maternal atopy secretion | #1 |
| atopic dermatitis adolescence | #1 |
| farm living symptoms | #1 |
| fever atopic | #1 |
| farming nasal samples | #1 |
| generations birth cohort | #1 |
| solids development | #1 |
| bacterial groups prevalence | #1 |
| 95 late introduction | #1 |
| gpra polymorphisms | #1 |
| regular farm | #1 |
| solar iii | #1 |
| wheeze sensitisation | #1 |
| unremitting wheeze | #1 |
| diagnosed fever 95 | #1 |
| analyses isaac phase | #1 |
| children early phenotypes | #1 |
| mrna expression tregs | #1 |
| throat microbiota | #1 |
| tempo method | #1 |
| stepwise protocol phase | #1 |
| kitchen moisture damage | #1 |
| “hygiene hypothesis | #1 |
| health influential factors | #1 |
| lumbricoides farmers children | #1 |
| atopic sensitization birth | #1 |
| associations pet contact | #1 |
| pollen dairy farms | #1 |
| farm wheeze phenotypes | #1 |
| risk gene asthma | #1 |
| lukas2 birth cohorts | #1 |
| asthma risk lca | #1 |
| class pasture | #1 |
| 035 iu sige | #1 |
| development asthma | #1 |
| censored immunological | #1 |
| fever spt cutoff | #1 |
| hygiene hypothesis endotoxin | #1 |
| farm animals cats | #1 |
| lca feeding patterns | #1 |
| animal farms substances | #1 |
| phase international | #1 |
| ascaris lumbricoides exposure | #1 |
| farm animal exposure | #1 |
| male parents receptors | #1 |
| 13 microbial influences | #1 |
| infancy jia | #1 |
| allergic rhinitis predictor | #1 |
| endotoxin allergy | #1 |
| common infections infants | #1 |
| asthma west germany | #1 |
| endotoxin exposure association | #1 |
| bronchial hyperreactivity adolescence | #1 |
| cord blood offspring | #1 |
| allergy prevention studies | #1 |
| spts specific ige | #1 |
| farming environments | #1 |
| selection bias responders | #1 |
| gabriel study | #1 |
| 1 ppg stimulation | #1 |
| identified polymorphisms asthma | #1 |
| protective farm environment | #1 |
| europe protection | #1 |
| epidemiologic phenotypes | #1 |
| allergy cohort methods | #1 |
| dampness childhood | #1 |
| farm reduced prevalence | #1 |
| analysis step package | #1 |
| asthma wisc | #1 |
| current wheeze benzene | #1 |
| interaction npsr1 polymorphisms | #1 |
| microbes epigenetic mechanisms | #1 |
| age increased diversity | #1 |
| development allergies | #1 |
| atopic eczema 95 | #1 |
| single taxa groups | #1 |
| farm dairy products | #1 |
| associations maternal sensitization | #1 |
| girls allergic rhinitis | #1 |
| humans hypopharynx moraxella | #1 |
| wheeze farm living | #1 |
| barns samples | #1 |
| associations indoor mould | #1 |
| multicenter cohort prevalence | #1 |
| yogurt cows milk | #1 |
| study parsifal | #1 |
| childhood asthma allergies | #1 |
| cd4creil13 | #1 |
| asthma turkish children | #1 |
| allergic rhinitis jia | #1 |
| auc spt | #1 |
| study prehireonset | #1 |
| treatment childhood asthma | #1 |
| spts agreement | #1 |
| persistence earlylife exposures | #1 |
| farm milk consumption | #1 |
| asthma symptoms adolescence | #1 |
| supplementation milk cla | #1 |
| protective effects asthma | #1 |
| lukas2 lca | #1 |
| data fetal growth | #1 |
| domestic cats child | #1 |
| microbiome data package | #1 |
| wheeze classes | #1 |
| late introduction solids | #1 |
| aor interquartile range | #1 |
| anthroposophic families validity | #1 |
| dgge health outcomes | #1 |
| allergen exposure associations | #1 |
| work overload school | #1 |
| association farm milk | #1 |
| unpasteurized cows milk | #1 |
| foxp3 cd4cd25hi | #1 |
| exposure farm children | #1 |
| farm animals childhood | #1 |
| animal sheds barns | #1 |
| traditional upbringing | #1 |
| ormdl3 gasdermin | #1 |
| food allergy yogurt | #1 |
| fpr2 aa | #1 |
| dust parameters development | #1 |
| annual concentrations benzene | #1 |
| netcomi network | #1 |
| linens child dust | #1 |
| predictor immune activation | #1 |
| il13cd4 cells ilcs | #1 |
| cowshed dust cde | #1 |
| asthma protective | #1 |
| microorganisms animal sheds | #1 |
| feeding cattle cowsheds | #1 |
| west germany allergic | #1 |
| children predominant hyperreactivity | #1 |
| 3785 adolescents | #1 |
| microorganisms farms | #1 |
| parents allergies | #1 |
| 95 asthmatic children | #1 |
| tregs cd4cd25hi | #1 |
| age dust microbiota | #1 |
| 17q21 locus method | #1 |
| antiasthma drugs children | #1 |
| repeated infections life | #1 |
| prevalence atopic sensitisation | #1 |
| bronchial obstruction hyperreactivity | #1 |
| life antibiotic exposure | #1 |
| hyperreaktivität | #1 |
| lumbricoides crude measure | #1 |
| cla allergoprotective capacity | #1 |
| occurrence allergy | #1 |
| network construction comparison | #1 |
| egg aor | #1 |
| model hyperreactivity | #1 |
| otus bacterial diversity | #1 |
| atopy interactions | #1 |
| protective allergic diseases | #1 |
| endotoxin levels samples | #1 |
| 57 911yearold children | #1 |
| dairying environment pollen | #1 |
| farm exposure igg4 | #1 |
| 95 allergen | #1 |
| dairy products protective | #1 |
| allergies year | #1 |
| farm animals asthma | #1 |
| eczema regions | #1 |
| h4 acetylation offspring | #1 |
| south bavarian | #1 |
| animal sheds 28 | #1 |
| 1120 german schoolchildren | #1 |
| no2 allergic sensitisation | #1 |
| identification immune phenotypes | #1 |
| childhood protective | #1 |
| allergy‐protective effects | #1 |
| asthma dresden | #1 |
| tbx21 hlx1 snps | #1 |
| psychosocial characteristics children | #1 |
| gene expression ilt4 | #1 |
| farmers children | #1 |
| cohorte pasture | #1 |
| 048 95 95 | #1 |
| adolescent aging asthma | #1 |
| 9 bronchodilators | #1 |
| incident wheezing | #1 |
| antipyretics increased risk | #1 |
| sum indicators | #1 |
| igg nglycosylation populations | #1 |
| immune activation populations | #1 |
| agreement association | #1 |
| 457 iu | #1 |
| diversity microbial exposure | #1 |
| farm rural children | #1 |
| topic puberty rhinitis | #1 |
| rhinoconjunctivitis sex | #1 |
| 1 year occurrence | #1 |
| alpine farm environments | #1 |
| childhood dampness | #1 |
| farm dwellings children | #1 |
| moisture damage kitchen | #1 |
| infections hygiene hypothesis | #1 |
| actinomycetes peak | #1 |
| allergies cohort | #1 |
| farming asthma | #1 |
| influential factors health | #1 |
| aa increased atp2a3 | #1 |
| specific exposures cows | #1 |
| atopic sensitization development | #1 |
| peak airborne moulds | #1 |
| farm milk | #1 |
| maturation gut microbiome | #1 |
| yoghurt asthma risk | #1 |
| allergic diseases protective | #1 |
| expression 17q21 | #1 |
| life inversely | #1 |
| children farm children | #1 |
| clec4e aa | #1 |
| coexpression igg1 | #1 |
| early age risk | #1 |
| farm lung function | #1 |
| 2nd followup challenges | #1 |
| nickel allergy asthma | #1 |
| mite sensitization aor | #1 |
| asthma 105 years | #1 |
| 9 10yold children | #1 |
| otitis fever | #1 |
| ige seasonal allergens | #1 |
| samples farm dwellings | #1 |
| children leipzig | #1 |
| lca pasture | #1 |
| bacterial signals atopy | #1 |
| tregs maternal atopy | #1 |
| pierced ears asthma | #1 |
| preschool wheezing aor | #1 |
| rhinitis predictor | #1 |
| exposure muramic | #1 |
| microbial exposure asthma | #1 |
| predominant hyperreactivity subsample | #1 |
| infants karelia | #1 |
| lukas2 umc | #1 |
| protective effects diversity | #1 |
| tnc risk gene | #1 |
| mite exposure risk | #1 |
| normal censored | #1 |
| gene expression ormdl3 | #1 |
| obstruktive atemwegserkrankungen | #1 |
| incident wheezing asthma | #1 |
| tnc asthma | #1 |
| children 7 yrs | #1 |
| solar 2nd followup | #1 |
| th2related genes | #1 |
| 95 endotoxin exposure | #1 |
| turkish children asthma | #1 |
| children beta 2agonists | #1 |
| asthma farm children | #1 |
| life chronic asthma | #1 |
| excessive sige production | #1 |
| farm farm children | #1 |
| protective exposures | #1 |
| immunity innate infant | #1 |
| protective diversity | #1 |
| comparison microbiome data | #1 |
| farms wheeze | #1 |
| current contact asthma | #1 |
| bactoscan | #1 |
| cumulative incidence finland | #1 |
| 95 grass pollen | #1 |
| increased expression ormdl3 | #1 |
| overweight dresden | #1 |
| protective childhood | #1 |
| actinomycetes cowsheds | #1 |
| worldwide asthma epidemic | #1 |
| food items year | #1 |
| allergies personal cleanliness | #1 |
| aa clec4e | #1 |
| gel variations gels | #1 |
| single microbial markers | #1 |
| str bhr | #1 |
| patients treg cells | #1 |
| new microscope | #1 |
| 585883 | #1 |
| 6 years subtypes | #1 |
| lca male phenotype | #1 |
| occurrence generations | #1 |
| insight environmental factors | #1 |
| cowsheds cattle | #1 |
| hlx1 polymorphisms influence | #1 |
| lower atopic sensitization | #1 |
| offspring atopic mothers | #1 |
| seasonal rural | #1 |
| crowding dry cough | #1 |
| higher specificity asthma | #1 |
| gpra gene | #1 |
| methods 2nd followup | #1 |
| phytohemagglutinin ormdl3 | #1 |
| physiciandiagnosed asthma groups | #1 |
| 168fold | #1 |
| asthmatics asthma phenotypes | #1 |
| gpra polymorphisms asthma | #1 |
| childhood asthma fever | #1 |
| prevent allergic diseases | #1 |
| allergoprotective capacity | #1 |
| mold subclinical inflammation | #1 |
| bhr str | #1 |
| allergies protective pet | #1 |
| npsr1 messenger receptors | #1 |
| cowsheds farm animals | #1 |
| allergies viral infections | #1 |
| farming protective farm | #1 |
| jobs potential confounders | #1 |
| tregs age | #1 |
| 20 fall volume | #1 |
| pets associations | #1 |
| followup solar cohort | #1 |
| evidence allergy prevention | #1 |
| asthma indoor exposure | #1 |
| farm protects | #1 |
| atopic embryonic | #1 |
| paediatric origins | #1 |
| wheeze asthma questions | #1 |
| pattern atopic sensitization | #1 |
| early phenotypes age | #1 |
| 17q21 polymorphisms | #1 |
| followup farm living | #1 |
| provocation time | #1 |
| cleanliness matter | #1 |
| consumption asthma | #1 |
| asthma concomitant asthma | #1 |
| provocation time bhr | #1 |
| parasitic infections predictor | #1 |
| atopic dermatitis increase | #1 |
| adolescence bronchial hyperreactivity | #1 |
| 5 years predictor | #1 |
| menarche allergic rhinitis | #1 |
| farm lifestyles | #1 |
| external microbial | #1 |
| strongest predictor atopy | #1 |
| atopy farm | #1 |
| ddhay fever | #1 |
| hypersensitivity infections | #1 |
| endotoxin level production | #1 |
| cε germline transcript | #1 |
| aetiology early years | #1 |
| asthma richness | #1 |
| phenotypes lca | #1 |
| allergic diseases cutoff | #1 |
| atopic embryonic allergic | #1 |
| computing microbial associations | #1 |
| leur relation | #1 |
| farming exposure childhood | #1 |
| farmers anthroposophic families | #1 |
| immunity newborn mothers | #1 |
| tolllike receptor farmers | #1 |
| protective farm asthma | #1 |
| shop milk | #1 |
| moderate‐to‐adequate | #1 |
| allergies cohort studies | #1 |
| milkassociated cla | #1 |
| farm allergic rhinitis | #1 |
| transmaternal asthma protection | #1 |
| serum ige levels | #1 |
| il4ra association | #1 |
| west germany munich | #1 |
| pcr sscp method | #1 |
| 812 children | #1 |
| hyperreactivity expiratory volume | #1 |
| asthma austria allergic | #1 |
| asthma german children | #1 |
| sige spt | #1 |
| children acrossolar cohort | #1 |
| protective cheese consumption | #1 |
| risk hutterite children | #1 |
| farmrelated exposures | #1 |
| allergies early phenotypes | #1 |
| protection allergic diseases | #1 |
| bamse npsr1 | #1 |
| children amish children | #1 |
| vehicle traffic asthma | #1 |
| rs11079788 | #1 |
| infant inflammation crp | #1 |
| asthma food sensitization | #1 |
| farm milk asthma | #1 |
| pets crowding | #1 |
| common inhalants | #1 |
| allergic germany | #1 |
| asthma risk class | #1 |
| heattreated milk samples | #1 |
| protective mechanisms asthma | #1 |
| maternal farm exposure | #1 |
| subsample predominant obstruction | #1 |
| farm children bavaria | #1 |
| preschool children rhinitis | #1 |
| association spink5 420lys | #1 |
| copd sod3 | #1 |
| ml1 cohort studies | #1 |
| atopy rural subjects | #1 |
| association ilt4 | #1 |
| egg positive sensitization | #1 |
| bacterial exposures associations | #1 |
| consumption farm milk | #1 |
| tbx21 hlx1 | #1 |
| w12 ddhay fever | #1 |
| epidemiological evidence consumption | #1 |
| otus farming | #1 |
| “atopic march | #1 |
| asthma bacterial diversity | #1 |
| kitchen living area | #1 |
| children amish farms | #1 |
| 30 amish | #1 |
| prenatal animal contact | #1 |
| childrens bedrooms cowsheds | #1 |
| methods solar cohort | #1 |
| blood ormdl3 | #1 |
| 624 children | #1 |
| atopic dermatitis jobs | #1 |
| west germany overweight | #1 |
| children road traffic | #1 |
| allergic rhinitis childhood | #1 |
| hrqol protective | #1 |
| breastfeeding length | #1 |
| infant design | #1 |
| pet contact infancy | #1 |
| contact farm | #1 |
| association haplotype studies | #1 |
| rora susceptibility gene | #1 |
| wheeze farmers children | #1 |
| richness farming | #1 |
| asthmatic children result | #1 |
| validity food questionnaire | #1 |
| unprocessed farm milk | #1 |
| school university life | #1 |
| 95 nonatopic asthma | #1 |
| farm homes homes | #1 |
| npsr1 interaction | #1 |
| protective farming | #1 |
| muramic acid concentration | #1 |
| dzl | #1 |
| newborn interleukin17 leukocytes | #1 |
| wheezing w12 | #1 |
| managing wheezing | #1 |
| solar cohort | #1 |
| phenotype health variables | #1 |
| hrqol rural farm | #1 |
| tregs life | #1 |
| farm milk exposure | #1 |
| hyperreactive children | #1 |
| aa hcs | #1 |
| protection asthma | #1 |
| analyses provocation time | #1 |
| 45yearold children protection | #1 |
| exposure mattress dust | #1 |
| children alliance asthma | #1 |
| stable dust extract | #1 |
| children severe atopy | #1 |
| 95 atopic sensitization | #1 |
| protective atopic sensitization | #1 |
| npsr1 rora | #1 |
| jobs asthma risk | #1 |
| subtypes atopic dermatitis | #1 |
| positive sensitization egg | #1 |
| incident wheezing women | #1 |
| allergic asthmatics asthmatics | #1 |
| accuracy regression approach | #1 |
| pets farm animals | #1 |
| allergyrisk factors | #1 |
| mold problems kitchen | #1 |
| allergy protective | #1 |
| childhood gondii seropositivity | #1 |
| east germany leipzig | #1 |
| potential confounders jobs | #1 |
| oropharyngeal microbiota children | #1 |
| gsdma phytohemagglutinin | #1 |
| 15ans | #1 |
| messenger surveys | #1 |
| bhr asthma child | #1 |
| ilcs inception | #1 |
| benzene current wheeze | #1 |
| allergic illnesses | #1 |
| dampness bronchial hyperreactivity | #1 |
| symptoms gender ratio | #1 |
| infancy case status | #1 |
| 12 months crowding | #1 |
| infant contact animals | #1 |
| environmental microbial | #1 |
| regulatory triggering receptor | #1 |
| bronchial response wheeze | #1 |
| abundances 6 otus | #1 |
| development atopic sensitisation | #1 |
| diseases farm | #1 |
| farm childhood asthma | #1 |
| farm exposure asthma | #1 |
| complementary food year | #1 |
| hc aa | #1 |
| phase stratified sample | #1 |
| living environment children | #1 |
| farm children microorganisms | #1 |
| tregs asthmatics | #1 |
| chapter 16 epidemiology | #1 |
| asthma interactions | #1 |
| questionnaire responses asthma | #1 |
| children unification | #1 |
| clinical examinations challenges | #1 |
| asthma tregs | #1 |
| demethylation foxp3 demethylation | #1 |
| mold problems children | #1 |
| current asthma age | #1 |
| acrossolar | #1 |
| epidemiologic phenotype | #1 |
| preschool dermatitis questionnaires | #1 |
| exposure farm | #1 |
| cowsheds childrens bedrooms | #1 |
| participation rates phase | #1 |
| polymorphisms lps recognition | #1 |
| 035 iu specificity | #1 |
| maschildren | #1 |
| lpa ppg stimulation | #1 |
| farming allergies | #1 |
| allergies addition | #1 |
| child environmental pollutants | #1 |
| wheezerelated latent classes | #1 |
| school children germany | #1 |
| interquartile range asthma | #1 |
| prediction quality snps | #1 |
| late onset menarche | #1 |
| lps recognition development | #1 |
| allergy exposures | #1 |
| neonatal mice ahr | #1 |
| unifying computational tool | #1 |
| reduced risk allergy | #1 |
| immune receptors birth | #1 |
| patients neutrophil inflammation | #1 |
| airborne fungi actinomycetes | #1 |
| 95 agmr | #1 |
| ilt4 cord blood | #1 |
| wheezing atopic sensitization | #1 |
| gsdma expression | #1 |
| cbmcs ormdl3 | #1 |
| exposures pieces | #1 |
| exposure protective | #1 |
| rs2738751 | #1 |
| newonset allergic rhinitis | #1 |
| anti‐asthmatic drugs | #1 |
| unprocessed cow | #1 |
| histamine challenges age | #1 |
| allergies childhood phase | #1 |
| advanced surveys | #1 |
| rora neuropeptide receptor | #1 |
| endotoxin levels stables | #1 |
| domestic asthma child | #1 |
| allergic rhinitis type | #1 |
| bhr fall | #1 |
| paper online questionnaires | #1 |
| stepwise procedure gene | #1 |
| 12 months doctor | #1 |
| consumption allergic | #1 |
| immune responsiveness life | #1 |
| heating children | #1 |
| network differences groups | #1 |
| seasonal allergens | #1 |
| maternal atopy tregs | #1 |
| kazal type spink5 | #1 |
| asthma aor | #1 |
| lpastimulation cord blood | #1 |
| protection hygiene hypothesis | #1 |
| rora snps | #1 |
| childhood allergy children | #1 |
| rora asthma susceptibility | #1 |
| antipyretics reduced risk | #1 |
| predictive models incidence | #1 |
| wheezing male respiratory | #1 |
| milk asthma | #1 |
| 115 iu | #1 |
| germany dresden | #1 |
| bronchial hyperreactivity childhood | #1 |
| airborne moulds actinomycetes | #1 |
| infant adolescent aging | #1 |
| followup solar | #1 |
| allergies generations | #1 |
| 5 years aor | #1 |
| crobiome data | #1 |
| childhood bronchial hyperreactivity | #1 |
| work ilc2s | #1 |
| asthma arabinogalactan | #1 |
| girls mechanism | #1 |
| recurrence atopic dermatitis | #1 |
| munich dresden | #1 |
| late introduction egg | #1 |
| harmful workplace exposure | #1 |
| 911 yrs | #1 |
| dgge asthma | #1 |
| infant genetic polymorphism | #1 |
| followup solar iii | #1 |
| authors grass arabinogalactans | #1 |
| unbalanced meat consumption | #1 |
| netcomi network construction | #1 |
| features anthroposophic lifestyle | #1 |
| asthma bacteria | #1 |
| dresden east germany | #1 |
| farm asthma | #1 |
| asthma questionnaire responses | #1 |
| asthma german | #1 |
| farmingrelated exposures | #1 |
| asthma bronchial response | #1 |
| farm exposure asthmatics | #1 |
| adolescents jobs | #1 |
| children farmers | #1 |
| ppg lpa ppg | #1 |
| protective factors strategies | #1 |
| aor farm exposures | #1 |
| wheeze active smoking | #1 |
| indoor microbiota development | #1 |
| puberty infant | #1 |
| recurrent unremitting wheeze | #1 |
| perinatal influences | #1 |
| netcomi functionality | #1 |
| grass pollen 95 | #1 |
| derp1lpa | #1 |
| allergies endotoxin | #1 |
| increased risks rhinoconjunctivitis | #1 |
| maternal farm | #1 |
| childhood asthma age | #1 |
| farm nonfarm children | #1 |
| lower atopy asthma | #1 |
| indicators total quantity | #1 |
| unhygienic contact | #1 |
| protection yogurt | #1 |
| followup work discontent | #1 |
| polysaccharides cde | #1 |
| germany breast feeding | #1 |
| pollen concentration feeding | #1 |
| asthma symptoms community | #1 |
| increased diversity food | #1 |
| atopic diseases association | #1 |
| environmental allergens variety | #1 |
| ddhay fever children | #1 |
| employment new onset | #1 |
| damage systemic inflammation | #1 |
| city air pollution | #1 |
| cattle childrens bedrooms | #1 |
| allergies existing cohort | #1 |
| hlx1 polymorphisms | #1 |
| farm fungi humans | #1 |
| unprocessed cows milk | #1 |
| life fungi humans | #1 |
| mattress dust association | #1 |
| childhood design | #1 |
| lpastimulation carriers | #1 |
| allergic rhinitis puberty | #1 |
| life maternal atopy | #1 |
| estonia environmental differences | #1 |
| wheezing children wheezing | #1 |
| diversity consumed types | #1 |
| atopic sensitization | #1 |
| 28 dust samples | #1 |
| rs11071559 | #1 |
| environments asthma | #1 |
| male poland quality | #1 |
| sige cutoff | #1 |
| early development wheeze | #1 |
| asthma allergies | #1 |
| hrqol farm children | #1 |
| amish hutterite | #1 |
| repeated episodes fever | #1 |
| treatment 9 bronchodilators | #1 |
| symptoms school age | #1 |
| phenotypes atopic | #1 |
| respiratory symptoms childhood | #1 |
| pasture cohort | #1 |
| feeding overweight | #1 |
| boys fever | #1 |
| 5–13‐year | #1 |
| relation late introduction | #1 |
| groups netcomi | #1 |
| source arabinogalactan | #1 |
| yogurt year | #1 |
| adolescent agriculture | #1 |
| 18 months protective | #1 |
| functionality network differences | #1 |
| swinesheds | #1 |
| personal cleanliness | #1 |
| polymorphisms card4 | #2 |
| associations lessaffluent countries | #2 |
| interval156 | #2 |
| difference endotoxin levels | #2 |
| card4 protein rhinitis | #2 |
| atopic eczema causation | #2 |
| standardized procedure centres | #2 |
| farms reference | #2 |
| affluent countries | #2 |
| 95 047 95 | #2 |
| children bronchial obstruction | #2 |
| parsifal study phenotypes | #2 |
| fdr clinical response | #2 |
| childhood obesoty | #2 |
| nocturnal asthma severity | #2 |
| farming families | #2 |
| asthma symptoms fever | #2 |
| farmers children children | #2 |
| values edna concentrations | #2 |
| asthma meeting | #2 |
| domestic child dust | #2 |
| il4 gene | #2 |
| breathomics asthma | #2 |
| collected dust indoor | #2 |
| tregs demethylation | #2 |
| allergic tolllike receptor | #2 |
| immune responses function | #2 |
| t2inflammation | #2 |
| fev1 fdr | #2 |
| higher foxp3 | #2 |
| positive spt sige | #2 |
| nonfarming families | #2 |
| microbial influences | #2 |
| association allergic diseases | #2 |
| negative volatile organic | #2 |
| lifelong farm exposure | #2 |
| association opposite direction | #2 |
| pregnancy specific ige | #2 |
| allergen levels socks | #2 |
| microbial agents association | #2 |
| 95 school level | #2 |
| age asthma cohort | #2 |
| study participants fieldworkers | #2 |
| allele specific ige | #2 |
| demethylation foxp3 | #2 |
| farm animals symptoms | #2 |
| individual level bhr | #2 |
| asthma adolescence | #2 |
| th17 markers | #2 |
| coaacetate | #2 |
| rora asthma | #2 |
| consumption farm | #2 |
| data maternal weight | #2 |
| allergic diseases allergies | #2 |
| dust samples levels | #2 |
| ifnγ levels snps | #2 |
| atopic sensitization upregulation | #2 |
| test inhalent | #2 |
| interactions asthma | #2 |
| isaac prevalence rates | #2 |
| farming mothers ppg | #2 |
| bm190th | #2 |
| nonfarming mothers lipid | #2 |
| expression innate | #2 |
| pha th17 lineage | #2 |
| 047 95 gg | #2 |
| childhood symptoms relapse | #2 |
| lipid lpa | #2 |
| consumption unpasteurized milk | #2 |
| farming environment mother | #2 |
| maternal immunity gondii | #2 |
| protection allergy | #2 |
| bhr west germany | #2 |
| serum levels c4ma3 | #2 |
| il4 il13 pathway | #2 |
| exposure farmers children | #2 |
| measles vaccination infection | #2 |
| 645 children | #2 |
| studies farms | #2 |
| increase parent | #2 |
| nonfarm children | #2 |
| aa hc | #2 |
| childhood phase | #2 |
| alliance ages | #2 |
| munich participants | #2 |
| exposure environmental microorganisms | #2 |
| cd14 genotypes asthma | #2 |
| environmental microorganisms | #2 |
| fever west germany | #2 |
| atopy early life | #2 |
| endotoxin allergen exposure | #2 |
| lessaffluent countries | #2 |
| phase prevalence rates | #2 |
| role maternal exposures | #2 |
| frequency nocturnal symptoms | #2 |
| traditional farm | #2 |
| multivariate analyses haying | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| halle west germany | #2 |
| prenatal farm exposure | #2 |
| childhood lca | #2 |
| lessaffluent countries adolescents | #2 |
| atopic smokers | #2 |
| genetic variation card4 | #2 |
| onset male recurrence | #2 |
| animal sheds pregnancy | #2 |
| animal exposure levels | #2 |
| immunoglobulin analyses children | #2 |
| farming exposure | #2 |
| indoor bacterial | #2 |
| ppg pha | #2 |
| human microbiota asthma | #2 |
| asthma hygiene hypothesis | #2 |
| cases objective measurements | #2 |
| lipid ppg | #2 |
| sod3 transcript | #2 |
| children farm | #2 |
| agriculture allergens | #2 |
| allergies farming status | #2 |
| c4ma3 biomarker | #2 |
| th17 lineage markers | #2 |
| asthma control pa | #2 |
| asthmaassociated | #2 |
| consumption unprocessed | #2 |
| fev1 fdr fdr | #2 |
| card4 21596 children | #2 |
| association atopic children | #2 |
| farming nonfarming families | #2 |
| fieldworkers house dust | #2 |
| processed cow | #2 |
| inflammatory diseases allergy | #2 |
| fieldworkers absolute levels | #2 |
| adult arm alliance | #2 |
| cd14 1721 children | #2 |
| ors affluent countries | #2 |
| doctors diagnosis aor | #2 |
| increase worldwide | #2 |
| imposed social isolation | #2 |
| asthmaassociated aor | #2 |
| life increased risk | #2 |
| messenger receptors tenascin | #2 |
| followup ndvi | #2 |
| prediction asthma | #2 |
| dander artemisia | #2 |
| germany asthma | #2 |
| positive maternal record | #2 |
| adult farmers role | #2 |
| school level 95 | #2 |
| pha farming mothers | #2 |
| rhinitis adolescents | #2 |
| siblings atopic children | #2 |
| age allergic rhinitis | #2 |
| patients childhood symptoms | #2 |
| frequency nocturnal asthma | #2 |
| pha maternal farming | #2 |
| exposure lifestyle factors | #2 |
| allergic disorders children | #2 |
| environmental microorganisms children | #2 |
| olive pollen dander | #2 |
| parent asthma | #2 |
| allele cd14 1721 | #2 |
| snps il4 gene | #2 |
| farmers child cross | #2 |
| asthma phenotypes negative | #2 |
| protein rhinitis allergic | #2 |
| bronchial challenge children | #2 |
| dresden higher greenness | #2 |
| living farms | #2 |
| eczema conjunctivitis eczema | #2 |
| farm children | #2 |
| hutterite farm children | #2 |
| eczema farm exposures | #2 |
| premature respiratory | #2 |
| cd14 maternal exposures | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| influence cord | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| probability incidence | #2 |
| lower atopy | #2 |
| current interpretation | #2 |
| farmers asthma symptoms | #2 |
| affluent countries centers | #2 |
| ages strongest associations | #2 |
| quartile work discontent | #2 |
| phase isaac | #2 |
| increased risk employment | #2 |
| current paracetamol 95 | #2 |
| alk samples | #2 |
| maternal contact protective | #2 |
| ga²len harmonization | #2 |
| causation environmental associations | #2 |
| microbial exposure study | #2 |
| life pvalues | #2 |
| farming families allergies | #2 |
| order sensitized patients | #2 |
| current exposure cats | #2 |
| sensitized patients order | #2 |
| neu5gc role | #2 |
| viable listeria spp | #2 |
| alk samples levels | #2 |
| atopic sensitization 14 | #2 |
| gmcsf ifnγ levels | #2 |
| highrisk predictors | #2 |
| improvements fdr | #2 |
| asthma protection | #2 |
| farming environment allergies | #2 |
| work discontent | #2 |
| cd14 1721 | #2 |
| immunoglobulin life | #2 |
| new onset wheezing | #2 |
| current symptoms asthmaassociated | #2 |
| asthma symptoms eczema | #2 |
| nonfarm homes children | #2 |
| wheeze bronchial responsiveness | #2 |
| alk samples fieldworkers | #2 |
| severe exacerbations feno | #2 |
| study design participation | #2 |
| alternaria animals animals | #2 |
| eczema lessaffluent countries | #2 |
| antiidiotypic aspergillosis | #2 |
| exposure life | #2 |
| atopic developing countries | #2 |
| allergic rhinitis adolescence | #2 |
| gels bands | #2 |
| histamine challenges | #2 |
| th2 cytokines ilc2s | #2 |
| statistical analysis performance | #2 |
| university baseline | #2 |
| allergies genetic variation | #2 |
| ages current paracetamol | #2 |
| rna russia | #2 |
| healthcare precision medicine | #2 |
| hc ca2 | #2 |
| immunoglobulin nod1 | #2 |
| relapse newonset | #2 |
| dendritic cells dust | #2 |
| peptidoglycan ppg | #2 |
| tbx21 gene | #2 |
| allergies cd14 expression | #2 |
| doctors diagnosed asthma | #2 |
| eczema symptom prevalence | #2 |
| asthma crp | #2 |
| strachan | #2 |
| severity spirometric measures | #2 |
| bronchial hyperresponsiveness children | #2 |
| antit2 biological therapy | #2 |
| antibiotic asthma risk | #2 |
| nocturnal asthma life | #2 |
| pa interrelations | #2 |
| nocturnal symptoms spirometry | #2 |
| environmental microbial exposure | #2 |
| levels alk samples | #2 |
| symptom control pa | #2 |
| participants dresden | #2 |
| bhr individual level | #2 |
| farmlike indoor microbiota | #2 |
| bronchitis east germany | #2 |
| south bavaria | #2 |
| igg4 ige levels | #2 |
| influences development | #2 |
| antiige therapy response | #2 |
| subsample children | #2 |
| time breastfed children | #2 |
| environmental exposures mother | #2 |
| socks alk samples | #2 |
| neu5gc exposure | #2 |
| atopic dermatitis childhood | #2 |
| milk cd14 | #2 |
| geneenvironment interactions asthma | #2 |
| excessive edna production | #2 |
| card4 21596 | #2 |
| affluent countries associations | #2 |
| role helminths | #2 |
| atopic diseases subjects | #2 |
| sputum extracellular | #2 |
| developing allergies | #2 |
| atopic eczema phenotypes | #2 |
| study participants levels | #2 |
| associations hscrp levels | #2 |
| fev1 score associations | #2 |
| dust endotoxin allele | #2 |
| isaac atopic eczema | #2 |
| fieldworkers dust collection | #2 |
| sensitization patterns inhalant | #2 |
| children affluent countries | #2 |
| cd4 cells offspring | #2 |
| children nonfarm homes | #2 |
| protect development | #2 |
| newonset asthma symptoms | #2 |
| highdna | #2 |
| children bronchial hyperresponsiveness | #2 |
| allergic asthma degradation | #2 |
| cats eczema | #2 |
| development atopic diseases | #2 |
| specificity lca | #2 |
| symptom control bmi | #2 |
| early immune maturation | #2 |
| paracetamol fever | #2 |
| card4 association | #2 |
| amish hutterite homes | #2 |
| artemisia olive pollen | #2 |
| eczema affluent | #2 |
| low sensitization rates | #2 |
| polymorphisms il13 gene | #2 |
| affluent countries eczema | #2 |
| eczema farmers children | #2 |
| life current symptoms | #2 |
| snps inflammatory diseases | #2 |
| 14 260 | #2 |
| early life prevalence | #2 |
| foxp3 demethylation | #2 |
| asthma symptoms children | #2 |
| il13 gene linkage | #2 |
| improvements fdr score | #2 |
| farming anthroposophic | #2 |
| relation dust endotoxin | #2 |
| dairying eczema | #2 |
| followup university | #2 |
| 17q21 | #2 |
| exposure farming | #2 |
| opposite direction children | #2 |
| amish farms | #2 |
| c4ma3 asthma | #2 |
| atopic dermatitis wheeze | #2 |
| asthma child dermatitis | #2 |
| socks dust | #2 |
| beta1 endotoxin | #2 |
| bhr tirana | #2 |
| asthma cohort | #2 |
| cd14 1721 association | #2 |
| 19th century allergic | #2 |
| exposures farm | #2 |
| higher greenness quartile | #2 |
| 95 protective factors | #2 |
| bacteriological properties | #2 |
| tregs cord blood | #2 |
| leipzig halle | #2 |
| eczema allergic dermatitis | #2 |
| wheeze 12 | #2 |
| arg130gln polymorphism linkage | #2 |
| children dresden | #2 |
| agmr 95 | #2 |
| cd4cd25hi foxp3 | #2 |
| farm milk pregnancy | #2 |
| associations atopy | #2 |
| allele card4 21596 | #2 |
| tirana mumbai | #2 |
| asthma parsifal | #2 |
| adaptor protein rhinitis | #2 |
| asthma observed | #2 |
| grass pollen dander | #2 |
| microbial exposure risk | #2 |
| pattern missing values | #2 |
| life rural children | #2 |
| doctors diagnosis | #3 |
| young adult europe | #3 |
| asthma major | #3 |
| current asthma rhinoconjunctivitis | #3 |
| paf allergic | #3 |
| bhr haplotypes humans | #3 |
| col29a1 polymorphisms | #3 |
| eosinophils matrix metalloproteinase | #3 |
| culture techniques study | #3 |
| bdnf polymorphisms asthma | #3 |
| asthma farming environment | #3 |
| t12888c | #3 |
| 53152 | #3 |
| severity moisture damage | #3 |
| atopic dermatitis aor | #3 |
| asthma genetic association | #3 |
| prenatal protection | #3 |
| farming farm | #3 |
| vivo expression irf1 | #3 |
| protection development | #3 |
| effects single snps | #3 |
| life allergic diseases | #3 |
| gni measurements | #3 |
| population german | #3 |
| fever aor | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| nf kappa polymorphism | #3 |
| pcdh1 polymorphisms associations | #3 |
| affluent countries atopy | #3 |
| blood allergen | #3 |
| children isaac phase | #3 |
| children farming | #3 |
| 9 mmp9 mmp9 | #3 |
| stat6 haplotype | #3 |
| asthma 1431c | #3 |
| maternal tlr | #3 |
| markers fetal growth | #3 |
| protein rhinitis | #3 |
| rural dwellings | #3 |
| domestic asthma | #3 |
| polymorphisms gm csf | #3 |
| throat microbiota asthma | #3 |
| prenatal asthma protection | #3 |
| atopic sensitisation | #3 |
| overweight germany | #3 |
| dennd1b chromosome | #3 |
| protocadherin‐1 | #3 |
| locus dennd1b | #3 |
| environmental dusts | #3 |
| sensitisation affluent countries | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| increased treg cells | #3 |
| ppg expression | #3 |
| moraxella colonization | #3 |
| animal sheds | #3 |
| anthroposophic children | #3 |
| pcdh1 asthma | #3 |
| domestic arthritis | #3 |
| cohort alliance | #3 |
| —study | #3 |
| biomaterial collection | #3 |
| allergyprotective | #3 |
| crude measure | #3 |
| characteristics respiratory | #3 |
| asthma snp rs2786098 | #3 |
| breastfeeding overweight | #3 |
| 1q31 locus | #3 |
| populations illness surveys | #3 |
| endotoxin dust samples | #3 |
| eczema strong association | #3 |
| eczema farmers | #3 |
| atopic asthma effects | #3 |
| allergy protection | #3 |
| united kingdom albania | #3 |
| childhood asthma community | #3 |
| 1q31 locus dennd1b | #3 |
| puberty risk factors | #3 |
| asthma atopic sensitization | #3 |
| protection contre | #3 |
| allergic inflammation polymorphisms | #3 |
| cytokine cluster bhr | #3 |
| individual level questionnaires | #3 |
| atopic female germany | #3 |
| col29a1 variants eczema | #3 |
| dogs exposure | #3 |
| mmp9 variants risk | #3 |
| tlr2 polymorphisms | #3 |
| microorganisms dust | #3 |
| jobrelated chronic stress | #3 |
| perennial allergens paf | #3 |
| dresden odds ratio | #3 |
| farming status | #3 |
| life development | #3 |
| protective farm | #3 |
| tlr2 receptor function | #3 |
| asthma endotoxin levels | #3 |
| european ancestry asthma | #3 |
| g1258a | #3 |
| auc asthma | #3 |
| samples 1q31 locus | #3 |
| role atopic sensitization | #3 |
| onset asthma child | #3 |
| atopy dresden | #3 |
| 45yearold children | #3 |
| disequilibrium rhinitis allergic | #3 |
| atopic diseases mutations | #3 |
| il5 il5 c746 | #3 |
| stat6 gene regulation | #3 |
| polymorphisms hlx1 gene | #3 |
| bias asthma bias | #3 |
| il15 il15 associations | #3 |
| dcs a20 induction | #3 |
| asthma genetic severity | #3 |
| atopic mothers | #3 |
| wheeze allergy | #3 |
| age 7–10 years | #3 |
| cd14 association | #3 |
| network construction | #3 |
| ferme | #3 |
| organic waste storage | #3 |
| rhinitis increased risk | #3 |
| susceptibility col29a1 expression | #3 |
| munich polymorphism | #3 |
| treatment asthma phenotypes | #3 |
| 1431c specific ige | #3 |
| asthma pcdh1 | #3 |
| allergic diseases children | #3 |
| il5 c746t | #3 |
| farm dwellings | #3 |
| bhr pcdh1 polymorphisms | #3 |
| farms asthma | #3 |
| blatella | #3 |
| work work overload | #3 |
| germany west german | #3 |
| parent prevalence | #3 |
| allergic phenotypes correction | #3 |
| today1 | #3 |
| phase international study | #3 |
| c746t | #3 |
| il15 associations | #3 |
| col29a1 eczema | #3 |
| hygiene hypothesis development | #3 |
| amino acid cx3cr1 | #3 |
| stat1 gene variations | #3 |
| substances protection | #3 |
| progeny asthma | #3 |
| col29a1 genetic variants | #3 |
| pcr sscp analysis | #3 |
| cowshed dust extract | #3 |
| t3085 | #3 |
| rhinoconjunctivitis paf | #3 |
| adam33 polymorphisms asthma | #3 |
| paf seasonal allergens | #3 |
| prevalence allergies | #3 |
| seasonal allergens atopy | #3 |
| crosssectional population | #3 |
| children negative spts | #3 |
| hlx1 gene development | #3 |
| hlx1 gene variants | #3 |
| occurrence rhinitis | #3 |
| nonatopic asthma 95ci | #3 |
| endotoxin milk | #3 |
| food correction | #3 |
| c39134a | #3 |
| female fetus immunity | #3 |
| responses innate | #3 |
| mmp9 influence development | #3 |
| microbiota farm | #3 |
| prenatal protection asthma | #3 |
| il5 c746 allergic | #3 |
| eczema international study | #3 |
| 1000 enfants | #3 |
| c2892 | #3 |
| hygiene hypothesis | #3 |
| irf1 interferon expression | #3 |
| asthma amino acid | #3 |
| allergic phenotype polymorphism | #3 |
| farm contact | #3 |
| monocytes lps stimulation | #3 |
| asthma subphenotypes | #3 |
| growing farm | #3 |
| rare tlr2 mutations | #3 |
| children african ancestry | #3 |
| forward initiative | #3 |
| duration prevalence | #3 |
| paf sensitisation | #3 |
| sige asthma | #3 |
| col29a1 expression eczema | #3 |
| farm dust endotoxin | #3 |
| bacterial diversity asthma | #3 |
| asthma protection progeny | #3 |
| eczema col29a1 | #3 |
| 280met | #3 |
| role neu5gc | #3 |
| eosinophil pathway genes | #3 |
| ile117thr | #3 |
| bavaria obesity | #3 |
| il15 gene variants | #3 |
| genetic variation crth2 | #3 |
| 95ci nonatopic asthma | #3 |
| allergy a20 induction | #3 |
| associations pcdh1 | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| prevalence asthma | #3 |
| gni rho | #3 |
| hlx1 gene | #3 |
| asthma identified | #3 |
| endotoxin levels asthma | #3 |
| dennd1b asthma | #3 |
| adam33 snps | #3 |
| lwoffii f78 | #3 |
| risk nonatopic asthma | #3 |
| sod3 extracellular matrix | #3 |
| role adam33 polymorphisms | #3 |
| asthma bordetella | #3 |
| asthma tolllike receptors | #3 |
| cowshed dust | #3 |
| german children munich | #3 |
| european science foundation | #3 |
| eosinophil pathway | #3 |
| sod3 variants | #3 |
| exposure helminths | #3 |
| role asthma prevalence | #3 |
| individual level centers | #3 |
| paracetamol risk | #3 |
| albania antibody specificity | #3 |
| f78 | #3 |
| food year | #3 |
| experimental asthma progeny | #3 |
| putative functional role | #3 |
| c1407t | #3 |
| tlr2 amino acid | #3 |
| rural areas europe | #3 |
| questionnaires physical examination | #3 |
| 3099 children | #3 |
| children bronchial hyperreactivity | #3 |
| asthma cattle | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| wheezing neutrophils | #3 |
| eczema isaac phase | #3 |
| lukas2 birth | #3 |
| regular contact | #3 |
| isaac polymorphisms | #3 |
| farm animals farm | #3 |
| countries endotoxin levels | #3 |
| mmp9 variants mmp9 | #3 |
| conjunctivitis paf | #3 |
| allergic asthmatics aa | #3 |
| 1431c | #3 |
| arabinogalactan isolated | #3 |
| crth2 influences development | #3 |
| col29a1 polymorphisms eczema | #3 |
| il15 gene asthma | #3 |
| allergic disequilibrium rhinitis | #3 |
| persistent flexural eczema | #3 |
| human genetic nod1 | #4 |
| questionnaires eczema | #4 |
| cough bronchitis | #4 |
| prenatal asthma | #4 |
| lukas2 | #4 |
| asthma symptoms adults | #4 |
| neonatal window | #4 |
| tolllike receptors receptor | #4 |
| occupational allergy risks | #4 |
| c746 | #4 |
| t2high asthma | #4 |
| asthma hygiene | #4 |
| eczema flg mutations | #4 |
| permanovas | #4 |
| genetic rhinitis allergic | #4 |
| fetal growth asthma | #4 |
| allergic dermatitis allergic | #4 |
| cats pregnancy | #4 |
| candidate genes wheeze | #4 |
| exposure cats | #4 |
| ilc2s human asthma | #4 |
| atopic dermatitis birth | #4 |
| antibiotics antipyretics | #4 |
| incident sensitization | #4 |
| prevalence random | #4 |
| minimum battery | #4 |
| glu420lys | #4 |
| fatty acids allergic | #4 |
| stable dust | #4 |
| cromolyns | #4 |
| doctors diagnosis asthma | #4 |
| adolescents duration | #4 |
| childhood protect | #4 |
| wheeze ige levels | #4 |
| lrti asthma | #4 |
| microbial compounds | #4 |
| il4r tlr4 | #4 |
| benzene no2 | #4 |
| groups taxa | #4 |
| cord blood lipid | #4 |
| farm environment development | #4 |
| fever year | #4 |
| fever eczema | #4 |
| early life basis | #4 |
| allergic diseases humans | #4 |
| leisure time activity | #4 |
| particle boluses | #4 |
| environmental dust samples | #4 |
| participants fieldworkers | #4 |
| flexural eczema | #4 |
| infections early | #4 |
| rare tlr2 | #4 |
| a20 induction | #4 |
| gabriel advanced | #4 |
| questionnaires populations | #4 |
| cx3cr1 polymorphisms | #4 |
| initial data analysis | #4 |
| aetiology asthma | #4 |
| childhood asthma | #4 |
| asthma induction | #4 |
| east germany bhr | #4 |
| feeding prevalence | #4 |
| children maternal overweight | #4 |
| genetic nod1 | #4 |
| col29a1 expression | #4 |
| asthma current symptoms | #4 |
| sounds rhinitis | #4 |
| asthma atopic diseases | #4 |
| licheniformis spores | #4 |
| sas genetics | #4 |
| genes il4r | #4 |
| wheezing onset | #4 |
| genotypes cd14 | #4 |
| current asthma bhr | #4 |
| immunity receptors | #4 |
| dust personal | #4 |
| n2267 | #4 |
| tlr2 mutations | #4 |
| fever 17 | #4 |
| col29a1 gene | #4 |
| development atopic sensitization | #4 |
| life childhood | #4 |
| 99th dahlem conference | #4 |
| lower risk allergy | #4 |
| crp blood leukocytes | #4 |
| allergic il5 | #4 |
| risk factor symptoms | #4 |
| cowsheds | #4 |
| anthroposophic families | #4 |
| rs2786098 | #4 |
| heating prevalence | #4 |
| cheese consumption | #4 |
| german children bavaria | #4 |
| early identification atopy | #4 |
| children munich | #4 |
| parent odds ratio | #4 |
| asthma 3 | #4 |
| bacillus licheniformis spores | #4 |
| microbes asthma | #4 |
| nonfarming | #4 |
| wheeze bhr | #4 |
| 5 13 years | #4 |
| adult lung disease | #4 |
| asthma auc | #4 |
| h20like homeobox | #4 |
| asthma phenotype children | #4 |
| parental allergic rhinitis | #4 |
| asthma symptoms association | #4 |
| indoor pollen | #4 |
| factors wheeze | #4 |
| promoter region arg130gln | #4 |
| eczema questionnaires adolescent | #4 |
| children farms | #4 |
| study centers phase | #4 |
| asthma snps | #4 |
| spt sige | #4 |
| questionnaires adolescent eczema | #4 |
| inhalant patients | #4 |
| agreement spt | #4 |
| birthcohort study | #4 |
| mother role | #4 |
| predictors visits | #4 |
| current symptoms asthma | #4 |
| environmental factors development | #4 |
| 95 gene expression | #4 |
| phase 2 allergies | #4 |
| predictor wheezing | #4 |
| increase eczema prevalence | #4 |
| common sensitizations | #4 |
| risk atopic dermatitis | #4 |
| alliance cohort | #4 |
| gene expression receptors | #4 |
| allergy international study | #4 |
| dietary habits children | #4 |
| late phenotype | #4 |
| children mattresses | #4 |
| endotoxin relation | #4 |
| lifetime prevalence asthma | #4 |
| development atopic | #4 |
| birth atopic dermatitis | #4 |
| pro27ser | #4 |
| stables farm milk | #4 |
| cd4cd25hi tregs | #4 |
| ige levels associations | #4 |
| occurrence atopic dermatitis | #4 |
| allergies children | #4 |
| asthma medication exposure | #4 |
| secretory receptors allergic | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| allergic ecuador eczema | #4 |
| exposure microbial | #4 |
| ormdl3 gsdma | #5 |
| hyperreactivity child | #5 |
| tbx21 gene variants | #5 |
| thr280met | #5 |
| risk atopic | #5 |
| tests bronchitis | #5 |
| tbx21 promoter activity | #5 |
| atopic eczema allergic | #5 |
| endotoxin protection | #5 |
| atopy flexural eczema | #5 |
| 95 reverse causation | #5 |
| milk consumption age | #5 |
| disinfectants asthma | #5 |
| cd14 gene expression | #5 |
| asthma medication 95 | #5 |
| c2892t | #5 |
| pattern sensitization | #5 |
| il13cd4 cells | #5 |
| tnc nps | #5 |
| allergystudy | #5 |
| hlx1 variants | #5 |
| il13cd4 | #5 |
| 2nd followup | #5 |
| combination hlx1 variants | #5 |
| moisture mold problems | #5 |
| n1046 | #5 |
| linkage development | #5 |
| subtypes risk | #5 |
| incident wheeze | #5 |
| eczema relation | #5 |
| allergic diseases exposure | #5 |
| rhinitis increase | #5 |
| neu5gc mice | #5 |
| tbx21 combination | #5 |
| tbx21 polymorphisms development | #5 |
| ors positive association | #5 |
| atopic sensitization asthma | #5 |
| mechanism environmental factors | #5 |
| ors atopy | #5 |
| atopic dermatitis age | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| rs3771300 | #5 |
| visits predictors | #5 |
| adulthood asthma | #5 |
| popular terms | #5 |
| severe atopy | #5 |
| dresden | #5 |
| cow milk samples | #5 |
| parental reports asthma | #5 |
| female germany allergic | #5 |
| moulds actinomycetes | #5 |
| puberty menarche | #5 |
| allergic rhinitis wheeze | #5 |
| atopy airway hyperresponsiveness | #5 |
| 26 farms | #5 |
| flexural eczema strength | #5 |
| jf1 msf | #5 |
| nonfarmers children | #5 |
| children validity | #5 |
| asthma endotoxins | #5 |
| combination hlx1 polymorphisms | #5 |
| 14452 | #5 |
| duration jobs | #5 |
| mmp9 influence | #5 |
| inverse association overweight | #5 |
| 95 populationattributable risk | #5 |
| processing intensity | #5 |
| asthma child dust | #5 |
| life questionnaires switzerland | #5 |
| genetic variants tbx21 | #5 |
| wisconsin infant | #5 |
| 2q14 | #5 |
| cd4cd25hi | #5 |
| rural subjects | #5 |
| childhood isaac phase | #5 |
| receptors innate immunity | #5 |
| children current wheeze | #5 |
| nod1 variation | #5 |
| verlaufsformen | #5 |
| phänotypen | #5 |
| genetic asthma | #5 |
| west german children | #5 |
| delayed manifestation | #5 |
| ige regulation | #5 |
| associations wheeze | #5 |
| farming mothers | #5 |
| cowshed | #5 |
| airway responsiveness age | #5 |
| asthma girls | #5 |
| cats risk factor | #5 |
| timing exposures | #5 |
| pregnancy year | #5 |
| allergen 95 | #5 |
| helsinki alert | #5 |
| sensitization atopic | #5 |
| trigger factors asthma | #5 |
| taxa groups | #5 |
| young adults methods | #5 |
| communitybased random sample | #5 |
| environmental dust | #5 |
| ornonaffluent | #5 |
| influence ige | #5 |
| dogs symptoms | #5 |
| milk exposure | #5 |
| exposure rhinitis | #5 |
| agriculture animals | #5 |
| lung health disease | #5 |
| consumption 4 years | #5 |
| participation behaviour | #5 |
| hlx1 polymorphisms development | #5 |
| milk odds | #5 |
| sounds surveys | #6 |
| distinct underlying mechanisms | #6 |
| 5 regions tao | #6 |
| systemic inflammation age | #6 |
| progression asthma | #6 |
| 16q12 region | #6 |
| cold air challenge | #6 |
| childhood asthma phenotypes | #6 |
| rora npsr1 | #6 |
| deubiquitinating enzyme tao | #6 |
| comprehensive questionnaires | #6 |
| longitudinal populations | #6 |
| complete screening | #6 |
| nd132656 | #6 |
| onset disease germany | #6 |
| allergic diseases | #6 |
| il33 17q12q21 | #6 |
| polymorphisms stat6 gene | #6 |
| rhinoconjunctivitis eczema | #6 |
| no2 current asthma | #6 |
| rhinoconjunctivitis atopic | #6 |
| children farming environment | #6 |
| fever wheezing | #6 |
| children positive spt | #6 |
| study rarer snps | #6 |
| farm nonfarm | #6 |
| natural atopic dermatitis | #6 |
| allergic epistasis | #6 |
| asthma authors | #6 |
| prevent allergic | #6 |
| eating environmental | #6 |
| overweight data | #6 |
| dust collection | #6 |
| bavarian preschool children | #6 |
| atemwegserkrankungen | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| lifestyle factors symptoms | #6 |
| steiner schools | #6 |
| responders frequency | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| allergic immunologic receptors | #6 |
| inversely asthma | #6 |
| asthma allergic sensitisation | #6 |
| childhood asthma genes | #6 |
| genetic variants time | #6 |
| asthma austria | #6 |
| hypertonic skin tests | #6 |
| current contact | #6 |
| new locus time | #6 |
| children east germany | #6 |
| pierced ears | #6 |
| central europe asthma | #6 |
| lowgrade inflammation hscrp | #6 |
| asthma context | #6 |
| allergens needed | #6 |
| bolus dispersion | #6 |
| microorganisms samples | #6 |
| yearly interviews | #6 |
| sensitisation exposure | #6 |
| susceptibility gene asthma | #6 |
| food allergy 95 | #6 |
| allergic markers | #6 |
| tlr1 tlr10 | #6 |
| 11094 | #6 |
| nonaffluent | #6 |
| central europe interactions | #6 |
| primary preventive strategies | #6 |
| 17q12q21 earlier onset | #6 |
| allergoprotective properties | #6 |
| allergy tests children | #6 |
| genetic variants 17q12q21 | #6 |
| dogs environmental exposure | #6 |
| sscp method | #6 |
| oropharyngeal microbiota | #6 |
| tests asthma | #6 |
| interactions farm exposures | #6 |
| pair male nod2 | #6 |
| asthma transition | #6 |
| isaac programme | #6 |
| 7 years association | #6 |
| parsifal | #6 |
| asthma genotypes | #6 |
| 939 children | #6 |
| fever atopy | #6 |
| european dairy farms | #6 |
| abschnitten | #6 |
| childhood aa | #6 |
| strategies disease | #6 |
| german nationality | #6 |
| pair deubiquitinating enzyme | #6 |
| data 7 years | #6 |
| lung barrier | #6 |
| devenues | #6 |
| countries albania | #6 |
| protection allergies | #6 |
| steiner school | #7 |
| fetal development allergic | #7 |
| reference exposure | #7 |
| children breast | #7 |
| endotoxin allergen | #7 |
| school age asthma | #7 |
| farm homes | #7 |
| infectious diseases phenotype | #7 |
| hypertonic sensitivity | #7 |
| secretory receptors | #7 |
| invading microorganism | #7 |
| hutterite children | #7 |
| juvenile inflammatory | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| wheeze atopy | #7 |
| preanalytix | #7 |
| fever atopic asthma | #7 |
| bhr current asthma | #7 |
| breastfeeding prevalence | #7 |
| influence neonatal | #7 |
| immunologic receptors allergic | #7 |
| nonfarm homes | #7 |
| children prognosis | #7 |
| environmental exposure endotoxin | #7 |
| 95 endotoxin | #7 |
| rhinitis early childhood | #7 |
| asthma fever | #7 |
| pasture study | #7 |
| infantis populations | #7 |
| environmental factors children | #7 |
| genetic predisposition role | #7 |
| child dust | #7 |
| farm life | #7 |
| isaac eczema | #7 |
| 5 harmonization | #7 |
| murine offspring | #7 |
| association cord blood | #7 |
| 15245 | #7 |
| seasonal sensitivity allergic | #7 |
| children regular contact | #7 |
| inverse association consumption | #7 |
| centers increase | #7 |
| pbmcs asthmatics | #7 |
| birth function | #7 |
| perennial allergen | #7 |
| allergic atopic embryonic | #7 |
| childhoodonset disease | #7 |
| allergy antibiotics | #7 |
| levels farm | #7 |
| atopic dermatitis association | #7 |
| lymphoid cells asthma | #7 |
| questionnaires phase | #7 |
| cells dust | #7 |
| paracetamol year | #7 |
| farm exposure | #7 |
| pasture birth | #7 |
| indoor moisture | #7 |
| amish children | #7 |
| viral infections development | #7 |
| level variety | #7 |
| biomarker immune activation | #7 |
| exposure farms | #7 |
| log2fold | #7 |
| large centres | #7 |
| symptoms adulthood | #7 |
| wheeze 12 months | #7 |
| exposure neu5gc | #7 |
| questionnaires allergic | #7 |
| polymorphisms il4 gene | #7 |
| stat1 gene | #7 |
| children international study | #7 |
| interleukin4 sequence analysis | #7 |
| lung sod3 | #7 |
| hypersensitivity male | #7 |
| foxp3 blood | #7 |
| steiner school children | #7 |
| pregnancy atopic dermatitis | #7 |
| atopic europe | #7 |
| european science | #7 |
| aerosol bolus dispersion | #7 |
| lower risk asthma | #7 |
| strategies asthma | #7 |
| adult farmers | #7 |
| asthma environmental factors | #7 |
| fieldworkers | #7 |
| childrens bedrooms | #7 |
| inhalant age | #7 |
| birth cohorts report | #7 |
| grass rphl | #7 |
| diversity introduction | #7 |
| highrisk occupations | #7 |
| asthma school age | #7 |
| functional phenotypes | #7 |
| asthma child conjunctivitis | #8 |
| amish child | #8 |
| lipid peptidoglycan | #8 |
| children anthroposophic | #8 |
| age 911 years | #8 |
| association food diversity | #8 |
| hrqol questions | #8 |
| eczema asthma child | #8 |
| diet year | #8 |
| asthma maternal smoking | #8 |
| asthma physiciandiagnosed asthma | #8 |
| children reference | #8 |
| association wheeze | #8 |
| il15 snps | #8 |
| study rural | #8 |
| bronchial histamine challenge | #8 |
| exposure dogs | #8 |
| 95 food allergy | #8 |
| allergy study | #8 |
| cows milk age | #8 |
| sensitization patterns | #8 |
| asthma atopic sensitisation | #8 |
| fever atopic sensitisation | #8 |
| p3×10−9 | #8 |
| crohns disease polymorphisms | #8 |
| diversity year | #8 |
| th2 cells ilc2s | #8 |
| asthma 08 | #8 |
| finlande | #8 |
| allergies childhood | #8 |
| p4×10−9 | #8 |
| il13 variants | #8 |
| allergy epidemiology | #8 |
| surveyed children | #8 |
| childhood asthma atopy | #8 |
| indoor microbiota | #8 |
| gabriela study | #8 |
| repeats sequence homology | #8 |
| p7×10−14 | #8 |
| asthmaprotective | #8 |
| asthma birth weight | #8 |
| p11×10−8 | #8 |
| university work | #8 |
| asthma bias | #8 |
| rs8076131 | #8 |
| sensitization mite | #8 |
| proteins dendritic cells | #8 |
| international variations | #8 |
| genetic risk asthma | #8 |
| 824 children | #8 |
| gabriela | #8 |
| ppg stimulation | #8 |
| antibiotics year | #8 |
| immunity gene expression | #8 |
| mice children | #8 |
| children anthroposophic families | #8 |
| chromosome 2q14 | #8 |
| chromosome childhoodonset disease | #8 |
| childhoodonset disease elevation | #8 |
| asthma analyses | #8 |
| inhalant europe | #8 |
| dogs risk factor | #8 |
| amino acid asthma | #8 |
| early age exposure | #8 |
| current asthma data | #8 |
| invertedu shape | #8 |
| 17q12q21 | #8 |
| age positive spts | #8 |
| factor analysis factor | #8 |
| highthroughput sequencing data | #8 |
| influence cytokine | #8 |
| c4ma3 | #8 |
| austrian schoolchildren | #8 |
| 3113 children | #8 |
| agmr | #8 |
| hlx1 | #8 |
| airwayrelated symptoms | #8 |
| atopic sensitization prevalence | #8 |
| igg1 galactosylation | #8 |
| bronchial hyper‐responsiveness | #9 |
| polymorphisms development | #9 |
| asthma infant | #9 |
| dennd1b | #9 |
| gwas approaches | #9 |
| role human asthma | #9 |
| tbx21 promoter | #9 |
| factors sensitization | #9 |
| 1 npsr1 | #9 |
| ecuador eczema | #9 |
| animals supplementation | #9 |
| ausprägungen | #9 |
| chromosome ige levels | #9 |
| igg4 ige | #9 |
| unprocessed milk | #9 |
| asthma antibiotics | #9 |
| relation environment | #9 |
| skinprick | #9 |
| regular exposure | #9 |
| rad50 gene chromosome | #9 |
| fcer1a susceptibility locus | #9 |
| asthma risk | #9 |
| autriche | #9 |
| relation asthma | #9 |
| allergic seasonal risk | #9 |
| symptoms 12 months | #9 |
| association wheezing | #9 |
| 1314yrolds | #9 |
| levels allergens | #9 |
| life female germany | #9 |
| atopic sensitization children | #9 |
| allergic inflammation patients | #9 |
| allergic preschool conjunctivitis | #9 |
| young german | #9 |
| prevalence atopic | #9 |
| teenagers asthma | #9 |
| study asthma | #9 |
| cord blood cytokines | #9 |
| drug development strategies | #9 |
| microbial exposure | #9 |
| low levels hscrp | #9 |
| association stat6 variation | #9 |
| life prenatal exposure | #9 |
| exposure farming environments | #9 |
| subspecies bifidobacterium | #9 |
| conjunctivitis cross | #9 |
| asthma allergy symptoms | #9 |
| life ahr | #9 |
| 1314 children | #9 |
| asthma symptoms baseline | #9 |
| microbial substances | #9 |
| asthma child | #9 |
| ribosomal 16s risk | #9 |
| col29a1 variants | #9 |
| asthma early life | #9 |
| asthma child child | #9 |
| eczema weight | #9 |
| farming environment | #9 |
| longitudinal follow‐up | #9 |
| kazal type | #9 |
| n7498 | #9 |
| partial nonresponders | #9 |
| npsr1 snps | #9 |
| allergic phenotypes | #9 |
| cytokines environmental | #9 |
| clinical response score | #9 |
| 5 european | #9 |
| positive spts | #9 |
| random subsample | #9 |
| asthma respiratory conditions | #9 |
| germany munich | #9 |
| ige levels gwas | #9 |
| rural farm | #9 |
| 105 years age | #9 |
| regulatory th17 cells | #9 |
| farm children children | #10 |
| consumption raw | #10 |
| adult cases controls | #10 |
| receptors immunity | #10 |
| genetic probability receptors | #10 |
| centers prevalence rates | #10 |
| gabriel advanced studies | #10 |
| indoor heating | #10 |
| latex children | #10 |
| humans hypersensitivity | #10 |
| house dust endotoxin | #10 |
| hormonal factors role | #10 |
| life allergen | #10 |
| asthma chromosome | #10 |
| asthma nocturnal | #10 |
| urban rural area | #10 |
| new onset rhinitis | #10 |
| 1992–2001 | #10 |
| bias exposure | #10 |
| missing values paper | #10 |
| study occupational | #10 |
| infection allergic | #10 |
| ratio asthma | #10 |
| mechanisms oral tolerance | #10 |
| ige levels asthma | #10 |
| substances development | #10 |
| mothers contact | #10 |
| bhr prevalence | #10 |
| blood samples tubes | #10 |
| 45 saline | #10 |
| phase protocol | #10 |
| international study asthma | #10 |
| prevalence differences | #10 |
| young german adults | #10 |
| production cord blood | #10 |
| predictors health utilization | #10 |
| ilt3 ilt4 | #10 |
| reservoir method | #10 |
| association new onset | #10 |
| context eczema | #10 |
| airway hyperresponsiveness children | #10 |
| n1138 | #10 |
| bdnf gene variants | #10 |
| farm exposures asthma | #10 |
| atopic dermatitis 95 | #10 |
| early life immunity | #10 |
| mattress dust | #10 |
| endotoxin muramic acid | #10 |
| rural school children | #10 |
| countries centres | #10 |
| association atopic | #10 |
| interrelations risk factors | #10 |
| leipzig east germany | #10 |
| new zealand bhr | #10 |
| samples persons | #11 |
| protective development | #11 |
| npsr1 polymorphisms | #11 |
| cytokines allergic inflammation | #11 |
| farm exposures | #11 |
| allergic asthma conjunctivitis | #11 |
| genotyped polymorphisms | #11 |
| tbx21 polymorphisms | #11 |
| fetal ige | #11 |
| reduced risk asthma | #11 |
| ige measurements | #11 |
| pregnancy early life | #11 |
| factors agriculture | #11 |
| association respiratory health | #11 |
| allergic disease children | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| asthma lower | #11 |
| health outcomes countries | #11 |
| allergy risks | #11 |
| tuberculosis notification rates | #11 |
| parsifal study | #11 |
| children rural | #11 |
| overweight body mass | #11 |
| early life development | #11 |
| asthma bacterial | #11 |
| school beginners | #11 |
| atopy | #11 |
| children school entry | #11 |
| wheeze year | #11 |
| newborn male polymorphism | #11 |
| transient wheezing | #11 |
| atopic dust | #11 |
| persistent uncontrolled asthma | #11 |
| occupational disinfectants | #11 |
| blood foxp3 | #11 |
| microbiome lung | #11 |
| lebensbedingungen | #11 |
| asthma risk participants | #11 |
| wheeze aor | #11 |
| farm buildings | #11 |
| german schoolchildren | #11 |
| active smoking association | #11 |
| subsequent development asthma | #11 |
| ige grass | #12 |
| asthmatic cohort | #12 |
| asthma candidate gene | #12 |
| participants allergic rhinitis | #12 |
| multicentre allergy | #12 |
| children low levels | #12 |
| rural environments | #12 |
| overweight breast | #12 |
| asthma disease humans | #12 |
| doctor asthma | #12 |
| child environmental | #12 |
| farm | #12 |
| asthma parent | #12 |
| munich west germany | #12 |
| skin prick testing | #12 |
| exposure asthma symptoms | #12 |
| association moisture | #12 |
| 95 nox | #12 |
| east germany munich | #12 |
| children exposed children | #12 |
| standard deviation skewness | #12 |
| validated questions | #12 |
| current paracetamol | #12 |
| sensitization birth | #12 |
| asthma epidemic | #12 |
| hypersensitivity immunity | #12 |
| german multicentre | #12 |
| mattress dust samples | #12 |
| infection analyses | #12 |
| pet contact | #12 |
| female humans hypersensitivity | #12 |
| birth cohorts asthma | #12 |
| incident asthma 95 | #12 |
| male respiratory | #12 |
| backgroundasthma | #12 |
| 7 years data | #12 |
| early priming | #12 |
| symptoms atopic | #12 |
| stepwise protocol | #12 |
| increase prevalence | #12 |
| fever exposure | #12 |
| young adults school | #12 |
| bhr wheeze | #12 |
| age 105 years | #12 |
| dermatitis phenotypes | #12 |
| management childhood asthma | #12 |
| cattle child | #12 |
| transient wheeze | #12 |
| polymorphisms bdnf gene | #12 |
| children background | #12 |
| damage mold | #12 |
| healthy children asthma | #12 |
| polymorphism asthma | #12 |
| children inhaled steroids | #13 |
| allergic sensitisation children | #13 |
| asthma community | #13 |
| sx1 | #13 |
| switzerland children | #13 |
| groups phenotype | #13 |
| northern indiana | #13 |
| local immunity | #13 |
| farm dust | #13 |
| children polymorphisms | #13 |
| farming exposures | #13 |
| asthma mental health | #13 |
| th1cells | #13 |
| asthma snp | #13 |
| subjects jobs | #13 |
| nod1 gene | #13 |
| n349 | #13 |
| rural schoolchildren | #13 |
| antibiotic exposure pregnancy | #13 |
| childhood isaac | #13 |
| developing microbiota | #13 |
| asthma outcomes patients | #13 |
| dresden germany | #13 |
| npsr1 | #13 |
| asthma bronchial | #13 |
| atopic eczema symptoms | #13 |
| eastern western germany | #13 |
| cord adult blood | #13 |
| spt specific ige | #13 |
| occupational exposure disinfectants | #13 |
| hygiene hypersensitivity | #13 |
| rhinitis allergens | #13 |
| ibd sle | #13 |
| childhood allergy | #13 |
| expression ormdl3 | #13 |
| wheezing ages | #13 |
| children raised | #13 |
| asthma rhinoconjunctivitis | #13 |
| farm animal contact | #13 |
| asthma nocturnal symptoms | #13 |
| polymorphisms influence | #13 |
| nonaffluent countries | #14 |
| 7 polymorphisms | #14 |
| breast feeding children | #14 |
| allergic sensitization age | #14 |
| rhinitis conjunctivitis | #14 |
| respiratory atopic | #14 |
| diseases atopic | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| increased risk age | #14 |
| air challenge | #14 |
| farming lifestyle | #14 |
| burden prevalence | #14 |
| innate infant | #14 |
| upper respiratory symptoms | #14 |
| detailed questionnaires | #14 |
| 3099 | #14 |
| asthma step | #14 |
| maternal sensitization | #14 |
| late introduction | #14 |
| il15 gene | #14 |
| preventive development | #14 |
| th2 commitment | #14 |
| changing gender | #14 |
| incidence rhinitis | #14 |
| farm rural | #14 |
| mrna expression vivo | #14 |
| standardised questionnaires | #14 |
| delayed introduction solids | #14 |
| introduction complementary food | #14 |
| 10‐year‐old children | #14 |
| polymorphisms ormdl3 | #14 |
| asthma1 | #14 |
| diabimmune study | #14 |
| positive spts age | #14 |
| symptoms rhinoconjunctivitis | #14 |
| german children | #14 |
| untypical | #14 |
| fx5 | #14 |
| atopic environmental | #14 |
| cross environmental exposure | #14 |
| role lung microbiome | #14 |
| exacerbations fev1 | #14 |
| epidemiological studies exposure | #15 |
| respective tlrs | #15 |
| asthma allergy | #15 |
| sensitization indoor allergens | #15 |
| children allele | #15 |
| bronchial responsiveness children | #15 |
| immunity asthma | #15 |
| unpasteurized | #15 |
| ahr male mice | #15 |
| allele evidence | #15 |
| mold problems | #15 |
| ω3 polyunsaturated | #15 |
| factors bronchial | #15 |
| skin prick tests | #15 |
| rhinitis puberty | #15 |
| association asthma symptoms | #15 |
| street residence | #15 |
| 17q21 locus | #15 |
| allergy risk | #15 |
| nocturnal symptoms | #15 |
| contact farm animals | #15 |
| children early | #15 |
| allele2 | #15 |
| pregnancy protective | #15 |
| puberty rhinitis | #15 |
| diabimmune | #15 |
| dogs children | #15 |
| bronchial hyperreactivity | #15 |
| n1133 | #16 |
| exposure atopic | #16 |
| microbial environment | #16 |
| lung microbiome health | #16 |
| hutterite | #16 |
| association atopy | #16 |
| increased food | #16 |
| diseases allergy | #16 |
| wheeze trajectories | #16 |
| newborn phenotype | #16 |
| microbial exposures | #16 |
| 80 chromosomes | #16 |
| clinical response measures | #16 |
| 7 year | #16 |
| bacteria respiratory tract | #16 |
| seasonal surveys questionnaires | #16 |
| asthma asthma risk | #16 |
| asthma farm | #16 |
| 9 11 | #16 |
| endotoxin house | #16 |
| protocadherin1 | #16 |
| allergic diseases childhood | #16 |
| nonatopic asthma children | #16 |
| multi‐centre study | #16 |
| sas institute | #16 |
| childhood asthma asthma | #16 |
| polymorphisms atopy | #16 |
| chronic asthma children | #16 |
| burden childhood asthma | #16 |
| age 7 years | #17 |
| aerosol bolus | #17 |
| bavarian | #17 |
| function school | #17 |
| single microbial | #17 |
| munich germany | #17 |
| neuropeptide receptor npsr1 | #17 |
| munich | #17 |
| dust extract | #17 |
| epidemiologic dermatitis | #17 |
| child allergic | #17 |
| allergic asthma aa | #17 |
| variants increase | #17 |
| asthma biomarkers humans | #17 |
| rhinoconjunctivitis | #17 |
| eczema exposure | #17 |
| pregnancy gene expression | #17 |
| ga2len skin | #17 |
| respiratory health children | #17 |
| humans preschool haemophilus | #17 |
| factors atopic | #17 |
| asthma 95 | #17 |
| levels microbial | #17 |
| asthma immune responses | #17 |
| asthma associations | #17 |
| animals domestic | #17 |
| atopy childhood | #17 |
| persistent sensitization | #17 |
| asthma environment | #17 |
| eczema 95 | #18 |
| col29a1 | #18 |
| children german | #18 |
| asthma phenotyping | #18 |
| maternallyacquired mice mice | #18 |
| immune adaptation | #18 |
| 7 yrs | #18 |
| polymorphism genetic receptors | #18 |
| underlying responses | #18 |
| atopy rhinitis | #18 |
| type employment | #18 |
| trajectories asthma | #18 |
| phenotypes children | #18 |
| meat children | #18 |
| anthroposophic lifestyle | #18 |
| increase childhood | #18 |
| female humans asthma | #18 |
| childrens mattresses | #18 |
| asthma exposure | #18 |
| ormdl3 gene | #18 |
| pregnancy 6 years | #18 |
| edna concentrations | #18 |
| asthma 6 years | #18 |
| protective microbiota | #18 |
| maternal contact | #18 |
| mef75 | #18 |
| current wheezers | #18 |
| german populations | #18 |
| cbmcs | #18 |
| cb production | #18 |
| measles infection | #18 |
| preschool dna ribosomal | #18 |
| wheeze | #18 |
| poor symptom control | #19 |
| birth 13 years | #19 |
| higher levels endotoxin | #19 |
| susceptibility human | #19 |
| asthma report | #19 |
| symptoms asthma | #19 |
| cary | #19 |
| sounds risk | #19 |
| ilt4 | #19 |
| receptors innate | #19 |
| german center | #19 |
| microbial association networks | #19 |
| receptors innate immune | #19 |
| asthma | #19 |
| farming activities | #19 |
| 3 years life | #19 |
| rural children | #19 |
| seasonal risk | #19 |
| children current | #19 |
| crp levels age | #19 |
| tcell phenotypes | #19 |
| asthma allergy development | #19 |
| developing asthma | #19 |
| life asthma risk | #19 |
| atopy phenotypes | #19 |
| child crosssectional studies | #19 |
| regulatory tolllike receptor | #19 |
| life exposures | #19 |
| atopic dermatitis studies | #19 |
| newonset symptoms | #19 |
| hscrp age | #19 |
| arg130gln | #19 |
| viable bacterial counts | #19 |
| innate mice models | #19 |
| expression treg | #19 |
| linkage disequilibrium polymorphisms | #19 |
| life diversity | #19 |
| asthma bronchiale | #19 |
| disease atopic | #19 |
| gender ratio | #20 |
| disease germany | #20 |
| unboiled | #20 |
| school university | #20 |
| npsr1 nps | #20 |
| symptoms wheeze | #20 |
| adults childhood | #20 |
| mice sod3 | #20 |
| breast feeding risk | #20 |
| children living | #20 |
| unhygienic | #20 |
| farm environments | #20 |
| atopy snps | #20 |
| inbred balb spores | #20 |
| specific ige food | #20 |
| haplotype studies | #20 |
| asthma trajectories | #20 |
| dust female humans | #20 |
| persistent uncontrolled | #20 |
| animal exposure | #20 |
| asthma nonatopic asthma | #20 |
| pvalues patients | #20 |
| stables | #20 |
| westernized countries | #20 |
| allergic disease prevalence | #20 |
| life farm | #20 |
| dermatitis early | #20 |
| isaac | #20 |
| infant colonization | #20 |
| 6 haplotype | #20 |
| gene expression measurements | #20 |
| gstm1 deficiency | #21 |
| environment lifestyle | #21 |
| children east | #21 |
| development allergic diseases | #21 |
| plasma erythrocyte membranes | #21 |
| children inhaled | #21 |
| germany humans germany | #21 |
| atopic asthma children | #21 |
| current asthma wheeze | #21 |
| bifidobacterium colonization | #21 |
| markers early | #21 |
| bhr 95 | #21 |
| tripeptidylpeptidases | #21 |
| farm environment | #21 |
| c589t | #21 |
| childhood background | #21 |
| tlr2 receptor | #21 |
| unremitting | #21 |
| studies eczema | #21 |
| asthma review | #21 |
| prevalence rates symptoms | #21 |
| network differences | #21 |
| pregnancy production | #21 |
| patients degradation | #21 |
| ige igg4 | #21 |
| hypersensitivity infant | #21 |
| environmental microbiome | #21 |
| eczema atopy | #21 |
| turkish children | #21 |
| rora | #21 |
| n1062 | #21 |
| pseudocroup | #21 |
| samples dust | #22 |
| chromosome asthma | #22 |
| β1→3glucans | #22 |
| isaac childhood | #22 |
| alleles asthma | #22 |
| seasonal risk factors | #22 |
| asthmatic phenotypes | #22 |
| living germany | #22 |
| endotoxin house dust | #22 |
| lower prevalences | #22 |
| objective sought | #22 |
| 17q21 asthma | #22 |
| r753q | #22 |
| effective airway | #22 |
| immune maturation | #22 |
| respiratory diseases children | #22 |
| lps risk | #22 |
| highschool | #22 |
| gabriel | #22 |
| crth2 th2 cells | #22 |
| npsr1 gene | #22 |
| exposure germany | #22 |
| 95 prenatal exposure | #22 |
| muramic acid | #22 |
| feeding obesity | #22 |
| childhood atopy | #22 |
| allergic rhinitis 95 | #22 |
| food diversity | #22 |
| neonatal immune responses | #22 |
| children adulthood | #23 |
| hillerød | #23 |
| symptoms atopic eczema | #23 |
| rapid alternative | #23 |
| 7 prevalence | #23 |
| bronchial challenge tests | #23 |
| new onset | #23 |
| association atopic asthma | #23 |
| gross national | #23 |
| childhood allergies | #23 |
| microbiota respiratory | #23 |
| asthma agents | #23 |
| farm childhood | #23 |
| nonlinear relations | #23 |
| breast feeding asthma | #23 |
| child cross | #23 |
| nonfarm | #23 |
| fecal microbiota children | #23 |
| isaac phase | #23 |
| traffic counts | #23 |
| asthma cats | #23 |
| single taxa | #23 |
| asthma 12 months | #23 |
| southern bavaria | #23 |
| haying | #24 |
| asthma cross | #24 |
| bronchitis child | #24 |
| asthma early | #24 |
| phenotypes childhood | #24 |
| asthma age | #24 |
| asthma prevention | #24 |
| contact livestock | #24 |
| current symptoms | #24 |
| exposure road traffic | #24 |
| allergic respiratory symptoms | #24 |
| asthma bhr | #24 |
| asthma 5 years | #24 |
| west german | #24 |
| eczema susceptibility | #24 |
| countrys | #24 |
| 2fold risk | #24 |
| differences asthma prevalence | #24 |
| tobit regression | #24 |
| asthma aa | #24 |
| doctor diagnosed | #24 |
| 4 phenotypes | #24 |
| gene expression immunity | #24 |
| dust endotoxin | #24 |
| children indoor | #24 |
| wheeze symptoms | #24 |
| allergic dermatitis | #24 |
| il13 pathway | #25 |
| exposure paracetamol | #25 |
| risk atopic diseases | #25 |
| expression ige | #25 |
| farm animals | #25 |
| prevention asthma | #25 |
| environmental determinants | #25 |
| 2 12 months | #25 |
| methods association | #25 |
| antibiotic year | #25 |
| igg1 ige | #25 |
| cytokines children | #25 |
| car traffic | #25 |
| sensitization early | #25 |
| 5030 | #25 |
| fev1 bhr | #26 |
| 3rd year | #26 |
| clinical phenotypes children | #26 |
| farms humans | #26 |
| levels mite | #26 |
| blood samples children | #26 |
| risk allergic sensitization | #26 |
| written questionnaire | #26 |
| trendwise | #26 |
| environmental asthma | #26 |
| early atopic | #26 |
| 5 european countries | #26 |
| child conjunctivitis | #26 |
| allergen sensitisation | #26 |
| increased treg | #26 |
| early phenotypes | #26 |
| risk factors probability | #26 |
| asthma syndrome | #26 |
| microbiota asthma | #26 |
| sputum eosinophils feno | #26 |
| card4 | #26 |
| wheezing childhood | #26 |
| consumption raw milk | #27 |
| asthmatic participants | #27 |
| asthma environmental | #27 |
| asthma child cross | #27 |
| ilt3 | #27 |
| muramic | #27 |
| prevalence atopic eczema | #27 |
| npsr1 asthma | #27 |
| visible mould | #27 |
| single snps | #27 |
| asthma childhood | #27 |
| children parental asthma | #27 |
| respiratory infections year | #27 |
| 035 iu | #27 |
| prevention allergic diseases | #27 |
| childhood origins | #27 |
| association childhood asthma | #27 |
| specific ige levels | #27 |
| wheeze childhood | #27 |
| allergens europe | #27 |
| 9 11 years | #27 |
| prevalence fever | #27 |
| children asthma symptoms | #27 |
| factors year | #27 |
| immune phenotypes | #28 |
| early identification children | #28 |
| recurrence persistence | #28 |
| higher hrqol | #28 |
| childhood asthma risk | #28 |
| gene asthma | #28 |
| 10 years data | #28 |
| pregnancy increase | #28 |
| feno fev1 | #28 |
| weekly diaries | #28 |
| ige therapy | #28 |
| east germany | #28 |
| atopic phenotypes | #28 |
| il13 polymorphisms | #28 |
| dust children | #28 |
| levels sensitization | #28 |
| host factors infection | #28 |
| analysis lca | #28 |
| primary prevention asthma | #29 |
| centers prevalence | #29 |
| anthroposophy | #29 |
| mite sensitization | #29 |
| preschool environmental | #29 |
| pediatric asthma patients | #29 |
| women males | #29 |
| early years life | #29 |
| polymorphisms identified | #29 |
| rad50 gene | #29 |
| adult agriculture | #29 |
| vivo age | #29 |
| bioair | #29 |
| questionnaires urban | #29 |
| farming | #29 |
| polymorphisms il13 | #29 |
| dust indoor | #29 |
| enhanced expression genes | #29 |
| pblc | #29 |
| acinetobacter lwoffii | #29 |
| boys asthma | #30 |
| biodiversity child | #30 |
| viral infections asthma | #30 |
| asthma childhood asthma | #30 |
| affluent | #30 |
| dismutase 3 | #30 |
| il10 snps | #30 |
| effective ways | #30 |
| incidence recurrence | #30 |
| moisture damage | #31 |
| atopic food | #31 |
| children diagnosed asthma | #31 |
| atopy children | #31 |
| questionnaires asthma | #31 |
| traditional farming | #31 |
| ribosomal preschool dna | #31 |
| enhancer marks | #31 |
| card4 nod1 | #31 |
| bronchial obstruction | #31 |
| centres countries | #31 |
| il10 polymorphisms | #31 |
| asthma atopic | #31 |
| probability persistence | #31 |
| persons european ancestry | #31 |
| childhood infectious | #31 |
| microbial environments | #32 |
| transferase deficiency | #32 |
| epidemiology asthma | #32 |
| studies dermatitis | #32 |
| obese children age | #32 |
| disease childhood | #32 |
| allergic diseases age | #32 |
| microbial components | #32 |
| asthma odds ratio | #32 |
| association paracetamol | #32 |
| cohorts asthma | #32 |
| linked polymorphisms | #32 |
| preschool day | #32 |
| infants countries | #32 |
| atopic diseases | #32 |
| african ancestry asthma | #32 |
| doctordiagnosed | #32 |
| gata3 gene | #32 |
| germany leipzig | #32 |
| living environments | #32 |
| rural regions | #32 |
| r2447x | #32 |
| européens | #32 |
| susceptibility asthma | #32 |
| huge burden | #32 |
| prick tests | #32 |
| symptoms childhood | #32 |
| asthma associations loci | #33 |
| bhr fev1 | #33 |
| allergic genetic epigenesis | #33 |
| eczema prevalence | #33 |
| imputation data | #33 |
| specificity skin tests | #33 |
| multiancestry association | #33 |
| immune cell enhancer | #33 |
| multiancestry association study | #33 |
| genetic epigenesis allergic | #33 |
| curve asthma | #34 |
| asthma atopic eczema | #34 |
| tests surveys | #34 |
| bacterial farms | #34 |
| new onset symptoms | #34 |
| development atopy | #34 |
| indoor mould | #34 |
| year life | #34 |
| infant contact | #34 |
| participants childhood | #34 |
| clec4e | #34 |
| asthma risk children | #34 |
| bradykinin receptor gene | #34 |
| health utilization children | #34 |
| endotoxins environmental | #34 |
| dust microbiota | #34 |
| participants questionnaire | #34 |
| pattern frequency | #34 |
| fascinating | #34 |
| mite allergen exposure | #34 |
| pregnancy maternal health | #34 |
| studies dust | #34 |
| western lifestyle | #35 |
| urbanrural differences | #35 |
| wingedhelix | #35 |
| 95 atopic dermatitis | #35 |
| raw cows milk | #35 |
| germany haplotypes | #35 |
| analysis steps | #35 |
| farms female | #35 |
| asthma conjunctivitis | #35 |
| western germany | #35 |
| asthma asthma phenotypes | #35 |
| anthroposophic | #35 |
| prick testing | #35 |
| risk asthma | #35 |
| tagging polymorphisms | #35 |
| endotoxin levels | #35 |
| preschool fatty acids | #35 |
| children cross | #35 |
| feno lung function | #35 |
| diseases rhinitis | #35 |
| nonatopic mothers | #35 |
| maternal vitamin intake | #36 |
| tolerance biomarkers | #36 |
| prevalence childhood asthma | #36 |
| exposure genetic | #36 |
| maternal exposures | #36 |
| asthma dendritic cells | #36 |
| 1 stimulation | #36 |
| leipzig | #36 |
| 16s rrna data | #36 |
| skin test reactivity | #36 |
| chapter 1 epidemiology | #36 |
| nasal samples | #37 |
| case status | #37 |
| incidence persistence | #37 |
| asthma candidate | #37 |
| native milk | #37 |
| 8263 | #37 |
| lifestyle environment | #37 |
| earlylife exposures | #37 |
| ril33 | #37 |
| allemagne | #37 |
| asthma allergens | #38 |
| mouse model asthma | #38 |
| reverse causation | #38 |
| dust asthma | #38 |
| itchy | #38 |
| amish | #38 |
| development allergic | #38 |
| allergy birth | #38 |
| asthma cough | #38 |
| ormdl3 expression | #38 |
| foxp3 levels | #38 |
| eczema environmental | #38 |
| nps npsr1 | #38 |
| life increased | #38 |
| maximum expiratory flow | #38 |
| wisc | #38 |
| atopy prevalence | #38 |
| endotoxin asthma | #38 |
| association ndvi | #38 |
| innate immunity genes | #38 |
| recurrence risk factors | #38 |
| c589 | #39 |
| maternal health pregnancy | #39 |
| protect children | #39 |
| haploview | #39 |
| genetic rhinitis | #39 |
| diversity environmental | #39 |
| igg nglycosylation | #39 |
| ige switching | #39 |
| traffic asthma | #39 |
| seasonal perennial | #39 |
| adulthood risk factors | #39 |
| levels house | #39 |
| allergic symptoms children | #39 |
| wheezing phenotypes | #39 |
| degradation patients | #39 |
| polymorphisms asthma | #39 |
| symptoms allergic | #40 |
| antibiotics development | #40 |
| 4606 | #40 |
| preschool conjunctivitis | #40 |
| biodiversity health | #40 |
| children bronchial | #40 |
| eczema | #40 |
| isolated polysaccharides | #40 |
| transcription 6 | #40 |
| mite exposure | #40 |
| animal farms | #40 |
| crosssectional studies | #40 |
| eczema phenotypes | #41 |
| german cities | #41 |
| small airway dysfunction | #41 |
| discotheques | #41 |
| allergens age | #41 |
| risk factors health | #41 |
| stress young | #41 |
| farm residence | #41 |
| effects asthma | #41 |
| treg cells patients | #41 |
| allergic child | #41 |
| asthma wheeze | #41 |
| food questionnaire | #42 |
| pcdh1 | #42 |
| onset year | #42 |
| bronchiale | #42 |
| polymorphism single nucleotide | #42 |
| microbiome data | #42 |
| 95 antibiotics | #42 |
| international patterns | #42 |
| dust female | #42 |
| worldwide variations | #43 |
| dermatitis food | #43 |
| sensitized subjects | #43 |
| time asthma | #43 |
| asthma food | #43 |
| increased regulatory | #43 |
| treg th17 cells | #43 |
| asthma onset | #43 |
| subspecies infantis | #43 |
| atp2a3 | #44 |
| asthma food allergy | #44 |
| facklamia | #44 |
| early childhood infections | #44 |
| developing countries children | #44 |
| work overload | #44 |
| cells cord | #44 |
| gsdma | #44 |
| 97th | #44 |
| increased risk symptoms | #44 |
| followup physical activity | #44 |
| atopic diseases asthma | #44 |
| national institute allergy | #44 |
| microbiome asthma | #44 |
| asthma cystic fibrosis | #44 |
| wide variations | #44 |
| diseases childhood | #44 |
| prevalence symptoms | #44 |
| sequential switching | #44 |
| exposure early life | #45 |
| sensitization inhalant | #45 |
| antiasthma drugs | #45 |
| animals pregnancy | #45 |
| dust endotoxins | #45 |
| questionnaire responses | #45 |
| traffic exposure | #45 |
| severe atopic eczema | #45 |
| 7445 | #45 |
| phenotype respiratory | #45 |
| fever 95 | #45 |
| biodiversity hypothesis | #45 |
| birth 12 months | #45 |
| bamse | #45 |
| atopic diseases children | #46 |
| prevalence diseases | #46 |
| asthma gwas | #46 |
| adolescence differences | #46 |
| prevalence current wheeze | #46 |
| humans hygiene | #46 |
| evidence gene | #46 |
| prevalence bhr | #46 |
| control physical | #46 |
| asthma cluster | #46 |
| receptor tolllike receptors | #46 |
| farm animal | #46 |
| spt reactivity | #46 |
| improvement reduction | #46 |
| 95 eczema | #47 |
| germany east | #47 |
| children atopic disease | #47 |
| international study | #47 |
| wheeze phenotypes | #47 |
| tirana | #47 |
| prevalence rhinoconjunctivitis | #47 |
| efraim | #47 |
| franche | #47 |
| factors asthma | #47 |
| analysis step | #47 |
| cluster children | #48 |
| frequent wheeze | #48 |
| asthma biological | #48 |
| wheeze age | #48 |
| breath volatile | #48 |
| perennial allergens | #48 |
| asthma risk loci | #48 |
| parental interviews | #48 |
| prevalences asthma | #48 |
| asthma adjusted | #48 |
| lung function spirometry | #48 |
| airways diseases | #48 |
| polymorphisms il4 | #48 |
| doctordiagnosed asthma | #48 |
| halle | #48 |
| fungal flora | #48 |
| milk farm | #49 |
| chromosome susceptibility | #49 |
| n228 | #49 |
| fcer1a | #49 |
| children paracetamol | #49 |
| children female humans | #49 |
| risk factors incidence | #49 |
| pcrsscp | #50 |
| beta13glucans | #50 |
| background atopic | #50 |
| unpasteurized milk | #50 |
| bacterial markers | #50 |
| exposures asthma | #50 |
| physiciandiagnosed | #50 |
| longum subsp infantis | #50 |
| diversity food | #50 |
| common chronic disease | #51 |
| identified polymorphisms | #51 |
| maintenant | #51 |
| populationattributable risk | #51 |
| conjugated mice mice | #51 |
| association atopic dermatitis | #51 |
| country prevalence | #51 |
| microbial burden | #51 |
| asthma dust | #51 |
| igg1 igg4 | #51 |
| association allergic | #51 |
| children cities | #51 |
| lwoffii | #51 |
| asthma maternal | #51 |
| allergy symptoms | #51 |
| ige sige | #52 |
| 9357 | #52 |
| itchy rash | #52 |
| specific protective | #52 |
| milk consumption | #52 |
| prevalence wheeze | #52 |
| sensitization children | #52 |
| age wheezing | #52 |
| eczema childhood | #52 |
| doctor diagnosis | #52 |
| gpra | #52 |
| bmi asthma | #52 |
| wheeze cough | #52 |
| geneenvironment interactions | #52 |
| infant study | #52 |
| epidemiologischen | #52 |
| indoor endotoxin | #52 |
| atopic eczema children | #53 |
| outdoor pollution | #53 |
| il13 gene | #53 |
| 2q32 | #53 |
| adam33 asthma | #53 |
| early life exposure | #53 |
| ige children | #53 |
| life exposure | #53 |
| children current asthma | #53 |
| nonmicrobial | #54 |
| female germany life | #54 |
| asthma odds | #54 |
| cross sectional studies | #54 |
| male prevalence | #54 |
| animals asthma | #54 |
| prevalence wheezing | #54 |
| estonian children | #54 |
| cough wheeze | #55 |
| stepwise procedure | #55 |
| samples farm | #55 |
| bacterial microbiota | #55 |
| prevalence association | #55 |
| year asthma | #55 |
| random samples | #56 |
| strong protective | #56 |
| alex study | #56 |
| visible mold | #56 |
| adult asthma patients | #56 |
| immunoglobulin interleukin13 | #56 |
| tuberculosis notification | #56 |
| atopy development | #56 |
| cd14 tolllike receptor | #56 |
| asthma atopy | #56 |
| maternal ige | #56 |
| mononuclear lipid | #57 |
| eczema flg | #57 |
| atopy wheeze | #57 |
| derp1 | #57 |
| prevention allergic | #57 |
| life atopic dermatitis | #57 |
| adam33 polymorphisms | #57 |
| mef50 | #57 |
| 3785 | #57 |
| member 1 polymorphism | #57 |
| pollutant exposure | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| diseases methods | #57 |
| early asthma | #58 |
| eczema female | #58 |
| total serum | #58 |
| hypersensitivity immunoglobulin | #58 |
| diseases children | #58 |
| specificity asthma | #58 |
| reported parents | #58 |
| stat6 gene | #58 |
| 1q31 | #59 |
| milk cla | #59 |
| th17 lineage | #59 |
| finland estonia | #59 |
| german participants | #59 |
| 6 years age | #59 |
| asthma morbidity children | #59 |
| farm families | #59 |
| iedap | #60 |
| preschool wheezing | #60 |
| birth school age | #60 |
| beta 2agonists | #60 |
| development childhood | #60 |
| rna yield | #60 |
| allergic surveys | #60 |
| predictors incidence | #60 |
| breastfed children | #61 |
| species colonization | #61 |
| atopy eczema | #61 |
| seasonal skin tests | #61 |
| implicated genes | #61 |
| exposure asthma | #61 |
| childhoodonset asthma | #62 |
| asthma birth | #62 |
| development airway hyperresponsiveness | #62 |
| persistence asthma | #62 |
| life immune | #62 |
| estonia finland | #62 |
| respiratory sounds | #62 |
| large german | #62 |
| immunoglobulin infant | #62 |
| cystic fibrosis abpa | #63 |
| exposure assessed | #63 |
| hyperreactivity bronchial | #63 |
| children regions | #63 |
| indoor allergen exposure | #63 |
| children role | #63 |
| dermatitis risk | #63 |
| total quantity | #63 |
| endotoxin level | #63 |
| atopic | #63 |
| asthma breast | #63 |
| helminth ascariasis ascaris | #64 |
| differential networks | #64 |
| allergenspecific ige | #64 |
| no2 benzene | #64 |
| children centers | #64 |
| dust parameters | #64 |
| newborn lymphocyte | #64 |
| animal contact | #65 |
| risk wheezing | #65 |
| healthy controls children | #65 |
| childhood allergic diseases | #65 |
| allergic rhinitis age | #66 |
| living area | #66 |
| prevalence current asthma | #66 |
| preschool haemophilus humans | #66 |
| dust extracts | #66 |
| sensitization allergic | #66 |
| umc | #66 |
| ga²len | #66 |
| atopic symptoms | #66 |
| immunological data | #66 |
| ige expression | #67 |
| biomarkers predictors | #67 |
| respiratory allergies | #67 |
| pa obesity | #67 |
| maternal atopy | #67 |
| 2 questionnaires | #67 |
| early wheeze | #68 |
| weight boys | #68 |
| antibiotic sales | #68 |
| mère | #68 |
| ige allergens | #69 |
| gene gene interaction | #70 |
| allergic disorders | #70 |
| asthma complex | #70 |
| atopic disease children | #70 |
| hypersensitivity immunization | #70 |
| suisse | #70 |
| sod3 | #70 |
| breathomics | #71 |
| unprocessed | #71 |
| tlr2 tlr1 | #71 |
| barns | #71 |
| occurrence progression | #71 |
| allergic sensitization children | #71 |
| prenatal vitamin | #71 |
| atopic rhinitis | #71 |
| small airway function | #71 |
| association occupational exposure | #72 |
| molecular fingerprinting | #72 |
| factor asthma | #72 |
| 158 95 | #72 |
| children wheeze | #72 |
| infantis | #72 |
| persistent asthma children | #72 |
| sounds respiratory | #73 |
| gni | #73 |
| ormdl3 | #73 |
| european ancestry association | #73 |
| onset allergic | #73 |
| severe eczema | #74 |
| food allergy asthma | #74 |
| west humans | #74 |
| exposure europe | #74 |
| risk wheeze | #74 |
| health services children | #74 |
| total serum ige | #75 |
| rfel | #75 |
| standardized procedure | #75 |
| asthmatic mothers | #75 |
| chromosome 17q21 | #75 |
| maternal immunity | #75 |
| asthma genome | #75 |
| children hrqol | #75 |
| symptoms eczema | #76 |
| rural differences | #76 |
| eczema children | #76 |
| food inhalant | #76 |
| microbial molecules | #76 |
| asthma case | #76 |
| allergy childhood | #76 |
| wheezing | #76 |
| diversity microbial | #77 |
| 9 mmp9 | #77 |
| hyperresponsiveness bhr | #77 |
| sexspecific association | #77 |
| asthma healthy | #77 |
| sensitisation children | #78 |
| wheezing illnesses | #78 |
| mothers asthma | #78 |
| childhood | #78 |
| rhinitis atopic | #78 |
| blood cytokines | #78 |
| 6399 | #78 |
| findings prevalence | #78 |
| years odds | #78 |
| edta tubes | #78 |
| turkish origin | #78 |
| neuropeptide receptor | #79 |
| 95 protection | #79 |
| interactions snps | #79 |
| milk yoghurt | #79 |
| seasonal asthma | #79 |
| genes innate immunity | #79 |
| cats child | #80 |
| dander | #80 |
| ige skin | #80 |
| forkhead box protein | #81 |
| microbial agents | #81 |
| prevalence respiratory | #81 |
| childhood wheeze | #81 |
| symptoms 12 | #81 |
| lower prevalence | #81 |
| development atopic dermatitis | #81 |
| age 45 | #82 |
| laryngitis | #82 |
| 13 14 | #82 |
| children european | #82 |
| age prevalence | #82 |
| concentrations so2 | #82 |
| ribosomal pcr | #82 |
| introduction solids | #82 |
| bacterial viral infections | #82 |
| current wheezing | #83 |
| microbial stimulation | #83 |
| reporter genetic predisposition | #83 |
| cleanliness | #83 |
| hypersensitivity risk | #83 |
| study pcr | #83 |
| study population patients | #83 |
| children siblings | #83 |
| total fat content | #83 |
| gut commensals | #83 |
| control pa | #84 |
| tests child | #84 |
| new asthma | #84 |
| oligoarticular juvenile | #84 |
| 4732 | #84 |
| specific exposures | #84 |
| européenne | #85 |
| α1 antitrypsin | #85 |
| bronchial responsiveness | #85 |
| atopy risk | #85 |
| single nucleotide rna | #85 |
| n134 | #85 |
| hyper responsiveness | #86 |
| comté | #86 |
| children feeding | #86 |
| bifidobacterium species | #86 |
| wheeze prevalence | #86 |
| ige levels | #86 |
| truck traffic | #86 |
| arabinogalactan | #86 |
| infant inflammation | #86 |
| age asthma | #87 |
| influential factors | #87 |
| 95 fever | #87 |
| genes asthma | #87 |
| exposure associations | #87 |
| visits asthma | #87 |
| analysis respiratory | #87 |
| tolllike receptors tlrs | #88 |
| allergy tests | #88 |
| exposure tobacco smoke | #88 |
| asthma polymorphisms | #88 |
| pollution allergens | #88 |
| rhinitis risk | #88 |
| bronchial hyper | #89 |
| asthma children | #89 |
| rphl | #89 |
| aged 6 | #89 |
| asthma phenotypes | #89 |
| allergic seasonal surveys | #90 |
| critical time window | #90 |
| children area | #90 |
| current exposure | #90 |
| newborn limit | #91 |
| development eczema | #91 |
| newborn leukocytes | #91 |
| joint workshop | #91 |
| filaggrin mutations | #91 |
| asthma school | #91 |
| mononuclear polymorphism | #92 |
| sensitisation | #92 |
| geführt | #93 |
| allergic rhinitis symptoms | #93 |
| south germany | #93 |
| preschool haemophilus | #93 |
| east west germany | #93 |
| rs2305480 | #93 |
| low levels exposure | #93 |
| experimental asthma | #93 |
| previous studies association | #93 |
| zpbp2 | #94 |
| pertussis infection | #94 |
| tregulatory cells | #94 |
| eczema symptoms | #95 |
| asthma common | #95 |
| greater consumption | #95 |
| asthma loci | #95 |
| nickel allergy | #95 |
| fed children | #95 |
| expression toll | #95 |
| university life | #95 |
| 16q12 | #95 |
| international variation | #95 |
| allergic sensitisation | #96 |
| cumulative prevalence | #96 |
| airway dysfunction | #96 |
| onset wheeze | #96 |
| dysbalance | #96 |
| lps recognition | #96 |
| nonfarmers | #96 |
| trigger factors | #96 |
| anaphylaxie | #96 |
| dust environmental | #96 |
| expression th1 | #96 |
| indoor factors | #97 |
| regulatory treg | #97 |
| 95 overweight | #97 |
| schoolchildren aged | #97 |
| city air | #97 |
| inhalant allergens | #97 |
| age 3 years | #98 |
| seasonal sensitivity | #98 |
| children germany | #98 |
| childhood adulthood | #98 |
| background asthma | #98 |
| tlr1 tlr2 | #98 |
| factors school | #98 |
| comprehensive questionnaire | #99 |
| seasonal surveys | #99 |
| current wheeze | #99 |
| eastern germany | #99 |
| asthma inflammation | #99 |
| years aor | #99 |
| children atopic | #99 |
| earlyonset asthma | #99 |
| rural school | #99 |
| preschool crosssectional studies | #100 |
| isaac questionnaire | #100 |
| childhood atopic dermatitis | #100 |
| raw cow | #101 |
| weight girls | #101 |
| expression measurements | #101 |
| genetic factors susceptibility | #101 |
| summarised | #101 |
| mef25 | #101 |
| tenascin tnc | #102 |
| risk factors persistence | #102 |
| retinoid acid | #102 |
| factors wheezing | #102 |
| ige concentrations | #102 |
| effects respiratory | #102 |
| hdm exposure | #103 |
| irf1 gene | #103 |
| sensitization eczema | #103 |
| children increased risk | #103 |
| years early | #103 |
| 4264 | #103 |
| children relation | #104 |
| sensitization childhood | #104 |
| exposure milk | #104 |
| hyperreactivity | #105 |
| arabinogalactans | #105 |
| pollen concentration | #105 |
| high‐sensitivity | #105 |
| hutterites | #105 |
| blood ige | #106 |
| animal dander | #106 |
| physiciandiagnosed asthma | #106 |
| wheezing disorders | #106 |
| questionnaires switzerland | #106 |
| prevalence atopy | #106 |
| children contact | #106 |
| socs4 | #107 |
| puberty age | #107 |
| underlying factor | #107 |
| detailed questionnaire | #107 |
| fever episodes | #108 |
| overweight 95 | #108 |
| breast feeding | #108 |
| inverse associations | #108 |
| complex syndrome | #109 |
| moulds | #109 |
| healthy children children | #109 |
| air pollution children | #109 |
| asthma wheezing | #109 |
| publication air pollution | #109 |
| allergic perennial rhinitis | #109 |
| genotype germany | #110 |
| female germany | #110 |
| rs7216389 | #110 |
| folgenden | #110 |
| atopic eczema humans | #110 |
| p≤003 | #110 |
| il4ra | #111 |
| parental questionnaire | #111 |
| tbox transcription factor | #112 |
| 1314 | #112 |
| olive pollen | #112 |
| environmental study | #112 |
| milk samples | #112 |
| female histones | #112 |
| phenotypes asthma | #113 |
| allergic | #113 |
| flg variants | #113 |
| indoor asthma | #113 |
| risk allergic | #113 |
| experimental allergic asthma | #113 |
| occupational allergy | #114 |
| parent reported | #114 |
| asthma sensitization | #114 |
| tests bronchial | #114 |
| allergic disease | #114 |
| mould exposure | #114 |
| challenge data | #114 |
| increased diversity | #115 |
| igg4 responses | #115 |
| notification rates | #115 |
| cord blood ige | #115 |
| cough children | #115 |
| foxp3 locus | #115 |
| exclusive breast feeding | #116 |
| aged 9 | #116 |
| regulatory th17 | #116 |
| immune responsiveness | #116 |
| glutathione transferase gst | #117 |
| children underwent | #117 |
| psychosocial characteristics | #117 |
| living rural | #118 |
| allergic sensitization | #118 |
| skinprick tests | #118 |
| indoor microbial | #118 |
| west germany | #118 |
| germany humans | #118 |
| ratio prevalence | #118 |
| reference children | #118 |
| skin prick | #119 |
| children wheezing | #119 |
| delayed introduction | #119 |
| switching immunoglobulin | #119 |
| ancestry asthma | #119 |
| childhood risk factors | #120 |
| fibrolysis | #120 |
| environment children | #120 |
| levels endotoxin | #120 |
| association chromosome | #120 |
| allergens asthma | #121 |
| factors rural | #121 |
| aliments | #121 |
| lung function measurements | #121 |
| dampness | #121 |
| vitamin supplementation pregnancy | #121 |
| symptom control | #121 |
| common aeroallergens | #121 |
| life early | #122 |
| preventive potential | #122 |
| 300 people | #122 |
| tlr10 | #122 |
| hayfever | #123 |
| frequency pattern | #123 |
| urban traffic | #123 |
| atopic manifestations | #124 |
| active asthma | #124 |
| germany prevalence | #124 |
| passive smoke exposure | #124 |
| severe eosinophilic asthma | #124 |
| il18r1 | #125 |
| immunologic tolllike receptor | #125 |
| potted plants | #125 |
| common inhalant | #125 |
| effects prevalence | #126 |
| prevalence allergic diseases | #126 |
| eczema patients | #126 |
| await | #126 |
| asthma background | #126 |
| 3 infections | #126 |
| paediatric studies | #126 |
| sensitization development | #126 |
| exposure pets | #126 |
| caspase recruitment domain | #127 |
| adaptive cells | #127 |
| environmental allergens | #127 |
| test reactivity | #127 |
| allergens child | #127 |
| prävalenz | #127 |
| 95 ors | #127 |
| exposure endotoxin | #127 |
| parent questionnaire | #127 |
| bdnf polymorphisms | #128 |
| microbial markers | #129 |
| bdnf gene | #129 |
| receptors male | #129 |
| medall | #130 |
| respiratory symptoms children | #131 |
| sensitization allergens | #131 |
| hypersensitivity respiratory | #131 |
| factors allergens | #131 |
| protein allergy | #131 |
| common allergens | #131 |
| test study | #131 |
| severe eosinophilic | #131 |
| asthma objective | #131 |
| expression receptors | #132 |
| immunoglobulin inflammation | #132 |
| effects development | #132 |
| male occupational | #132 |
| asthma adolescent | #132 |
| diseases asthma | #132 |
| understanding natural | #133 |
| early age | #133 |
| bavaria | #133 |
| pollen prevalence | #133 |
| age 7 | #133 |
| allergy | #134 |
| dpp10 | #134 |
| 7 years age | #134 |
| prevalence rhinitis | #135 |
| childhood risk | #135 |
| body composition bmi | #135 |
| crth2 | #135 |
| 95 ages | #135 |
| allergic phenotype | #136 |
| 60 iu | #136 |
| eczema risk | #136 |
| asthma young | #136 |
| bronchial response | #136 |
| snps asthma | #137 |
| exposure children | #137 |
| ga2len | #137 |
| actinomycetes | #137 |
| ms4a2 | #137 |
| mechanisms asthma | #137 |
| 6 7 | #137 |
| régions | #138 |
| pollutants allergens | #138 |
| snps interactions | #138 |
| asthma atopic dermatitis | #138 |
| reduced prevalence | #138 |
| mattress | #138 |
| asthma development | #138 |
| sensitized children | #138 |
| allergen levels | #139 |
| sebacate | #139 |
| listeria spp | #139 |
| 3 14 | #139 |
| milk animals | #139 |
| pollution asthma | #139 |
| serum ige | #139 |
| largest reduction | #140 |
| tregs foxp3 | #140 |
| pasture | #140 |
| exposure symptoms | #140 |
| microbiota children | #140 |
| duration type | #140 |
| exposure indoor | #141 |
| asthma genes | #141 |
| age 6 years | #141 |
| factors difference | #142 |
| cla content | #142 |
| n183 | #142 |
| questionnaires illness surveys | #142 |
| asthma bronchitis | #142 |
| indoor allergens | #142 |
| susceptibility children | #142 |
| pregnancy early | #143 |
| unifrac | #143 |
| inconclusive | #144 |
| asthma defined | #144 |
| snps chromosome | #144 |
| pet exposure | #144 |
| incident asthma | #144 |
| exposure year | #144 |
| replication association | #144 |
| children allergy | #145 |
| dermatitis asthma | #145 |
| onset menarche | #145 |
| expositions | #145 |
| prematurely born children | #146 |
| lower airways | #146 |
| allergy testing | #146 |
| airway mechanics | #146 |
| prevalence skin | #146 |
| health outcomes children | #146 |
| interleukin13 interleukin4 | #146 |
| original article | #147 |
| study centers | #147 |
| biomarkers child | #147 |
| association early | #148 |
| germany west | #148 |
| feno patients | #148 |
| children 6 | #148 |
| early immune | #149 |
| atopic outcomes | #149 |
| indoor allergen | #149 |
| perennial rhinitis allergic | #150 |
| pregnancy respiratory | #150 |
| fall fev1 | #150 |
| 105 years | #151 |
| wheezing children | #151 |
| prevalence childhood | #151 |
| wheeze children | #151 |
| confer protection | #151 |
| profound differences | #151 |
| exposure increased | #152 |
| established asthma | #152 |
| immunomodulatory molecules | #152 |
| bhr | #152 |
| children review | #152 |
| environmental exposure | #152 |
| distribution asthma | #152 |
| consumption dairy products | #152 |
| wheeze asthma | #153 |
| hens egg | #153 |
| asthma dermatitis | #153 |
| function measurements | #153 |
| tagging single | #153 |
| common respiratory | #153 |
| cd28null | #154 |
| hormonal factors | #154 |
| onset association | #155 |
| tests sex factors | #155 |
| bronchial challenge | #155 |
| neighboring countries | #155 |
| atopic children | #156 |
| association asthma | #156 |
| severity frequency | #157 |
| gene 3 | #157 |
| neu5gc | #157 |
| absolute levels | #157 |
| positive spt | #157 |
| development allergy | #157 |
| lower diversity | #158 |
| early environmental | #158 |
| bacterial lysates | #158 |
| asthma females | #158 |
| paediatric asthma | #158 |
| prevention allergy | #159 |
| patients controlled asthma | #159 |
| children asthma | #159 |
| developing immune | #159 |
| reported prevalence | #160 |
| spts | #160 |
| children homes | #160 |
| german adults | #160 |
| microbiome diversity | #160 |
| children rhinitis | #160 |
| allergic seasonal | #160 |
| wheeze rhinitis | #161 |
| preventive measure | #161 |
| newborn longitudinal | #161 |
| asthma presence | #161 |
| atopy asthma | #161 |
| immune pathways | #162 |
| children lower | #162 |
| female humans allergic | #162 |
| parental asthma | #162 |
| specific ige | #163 |
| exposure prevalence | #163 |
| environmental associations | #163 |
| perennial rhinitis | #163 |
| kindl | #164 |
| sensitised | #164 |
| sscp | #164 |
| asthma ige | #165 |
| atopic dermatitis | #165 |
| children sensitized | #165 |
| atopic eczema | #165 |
| 5q31 | #166 |
| epidemiologie | #166 |
| infant respiratory | #166 |
| ige asthma | #166 |
| feeding child | #166 |
| illness surveys questionnaires | #166 |
| studies exposure | #167 |
| adolescent allergens | #167 |
| air pollutant concentrations | #167 |
| disease life | #167 |
| preadolescent children | #167 |
| preschool cross | #167 |
| year children | #168 |
| years lung | #168 |
| current asthma | #168 |
| workplace young | #169 |
| regulatory treg cells | #169 |
| airway size | #169 |
| stratification patients | #169 |
| 2688 | #169 |
| chronic inflammatory disease | #170 |
| nucleotide rna | #171 |
| adolescent analysis | #171 |
| inhalant | #171 |
| aged 13 | #171 |
| sensitization pollen | #171 |
| skin prick test | #172 |
| sheds | #172 |
| prevalence current | #172 |
| studien | #172 |
| ifnγ levels | #172 |
| endotoxins female | #172 |
| nucleotide pregnancy | #172 |
| unifying concept | #173 |
| risk score model | #173 |
| risk atopy | #174 |
| antipyretics | #174 |
| small airway | #175 |
| mice asthma | #175 |
| patients nocturnal | #175 |
| female humans questionnaires | #175 |
| asthma attack | #176 |
| sensitization common | #176 |
| school level | #176 |
| repeated infections | #176 |
| serine protease inhibitor | #176 |
| life respiratory function | #177 |
| wheezers | #177 |
| situ hybridization infant | #177 |
| sensitization pattern | #177 |
| aa patients | #178 |
| 9p24 | #178 |
| genetic severity | #178 |
| childhood infections | #178 |
| sensitization asthma | #178 |
| childhood adolescence | #179 |
| studies environmental | #179 |
| traffic characteristics | #179 |
| sputum neutrophils | #179 |
| standardized methodology | #179 |
| w12 | #179 |
| objective measurements | #179 |
| nocturnal asthma | #179 |
| socks | #180 |
| asthma genetic | #180 |
| breastfed infant | #180 |
| lung function testing | #181 |
| mattresses | #181 |
| children environmental | #181 |
| environmental predictors | #181 |
| bacterial count | #181 |
| immunemediated diseases | #182 |
| differences hrqol | #182 |
| dust levels | #182 |
| dermatitis children | #182 |
| vitamin asthma | #182 |
| tlr signaling | #183 |
| children levels | #183 |
| vocational training | #183 |
| german population | #183 |
| environmental microbiology | #183 |
| exposure humans | #183 |
| mögliche | #183 |
| incidence allergic | #185 |
| school district | #185 |
| life prevalence | #185 |
| work asthma | #186 |
| protein child | #187 |
| asthma body | #188 |
| selfselection | #188 |
| qpcrs | #188 |
| development allergic disease | #188 |
| tests children | #188 |
| environmental exposures | #188 |
| childhood early adulthood | #188 |
| tlr genes | #189 |
| jf1 | #189 |
| wheezing age | #190 |
| early wheezing | #190 |
| mother pregnancy | #190 |
| association antibiotic | #190 |
| bacterial groups | #190 |
| muscle mass patients | #190 |
| type duration | #190 |
| inversely | #190 |
| atopic dermatitis children | #191 |
| blood gene | #191 |
| cd14 gene | #191 |
| dry cough | #191 |
| longum subsp | #192 |
| adjusted irr | #192 |
| pyroglyphidae | #192 |
| adam33 | #193 |
| model allergic | #193 |
| milk serum | #193 |
| cε | #193 |
| estonian | #195 |
| prevalence severity | #195 |
| eosinophilic asthma | #195 |
| caspase recruitment | #196 |
| enthusiasm | #197 |
| germany switzerland | #197 |
| review asthma | #197 |
| earlylife | #198 |
| questionnaire data | #198 |
| representative population | #199 |
| decreased prevalence | #199 |
| rhinitis eczema | #199 |
| upper lower airways | #200 |
| bacteria role | #202 |
| complex interplay | #202 |
| allergy infectious diseases | #202 |
| patients europe | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| paediatrician | #203 |
| phenotyped | #204 |
| difference prevalence | #204 |
| patients aa | #204 |
| 13 years age | #205 |
| amebocyte | #205 |
| new locus | #205 |
| dermatitis atopic | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| asthma respiratory symptoms | #207 |
| factors atopy | #207 |
| asthma methods | #207 |
| karelia | #208 |
| allergic asthmatics | #208 |
| male phenotype | #208 |
| studies germany | #208 |
| diagnosed asthma | #208 |
| prevalence obesity | #209 |
| sensitization age | #209 |
| col4a3 | #209 |
| newborn logistic | #209 |
| studies cytokines | #209 |
| higher diversity | #209 |
| glycolylneuraminic acid | #209 |
| innate adaptive immunity | #209 |
| core microbiome | #210 |
| bhr asthma | #210 |
| symptoms children | #210 |
| epithelial barrier function | #210 |
| bronchial provocation | #210 |
| cats dogs | #211 |
| influence development | #211 |
| exposure sensitization | #211 |
| low prevalence | #211 |
| birth 6 | #212 |
| tlr4 cd14 | #212 |
| methodssubjects | #212 |
| asthma allergic | #212 |
| asthma animals | #212 |
| atopic dermatitis asthma | #212 |
| cohort methods | #213 |
| patients uncontrolled asthma | #213 |
| 1872 | #213 |
| exposure allergens | #213 |
| distinct clusters | #213 |
| asthma allergic diseases | #214 |
| prevalence allergic | #214 |
| 00035 | #214 |
| rural environment | #214 |
| reverse causality | #214 |
| expression cd14 | #214 |
| workplace exposure | #214 |
| life allergic | #215 |
| regulatory responses | #216 |
| mast cell chymase | #216 |
| obesity overweight | #216 |
| il2rb | #218 |
| atopic female | #218 |
| causation | #219 |
| geneticist | #219 |
| disinfectants | #219 |
| microbial products | #219 |
| child dna | #219 |
| steiner | #220 |
| allergy development | #220 |
| variants asthma | #220 |
| pierced | #220 |
| method participants | #221 |
| schistosoma schistosomiasis | #221 |
| homogenised | #221 |
| sensitization rates | #222 |
| 90 children | #222 |
| increased asthma | #222 |
| symptoms baseline | #223 |
| environmental epidemiology | #223 |
| groups asthma | #224 |
| sibship size | #225 |
| german study | #225 |
| alpha1 antitrypsin | #226 |
| sensitization allergen | #226 |
| conjunctivitis allergic | #226 |
| german | #226 |
| provocative concentration | #227 |
| school age | #227 |
| lung health | #228 |
| test spt | #228 |
| allergic diseases asthma | #228 |
| data asthma | #228 |
| specific stimulation | #228 |
| 95 obesity | #228 |
| wheezing asthma | #229 |
| tuberculosis prevalence | #229 |
| healthy worker | #229 |
| understanding asthma | #229 |
| road traffic | #229 |
| asthma allergic rhinitis | #230 |
| butyryl | #230 |
| cord blood cells | #230 |
| asthma phenotype | #230 |
| umwelt | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| discontent | #232 |
| health variables | #232 |
| living conditions | #232 |
| 20 fall | #232 |
| subgroup children | #232 |
| nonallergic asthma | #232 |
| prevalence overweight | #233 |
| innate leukocytes | #233 |
| lively | #233 |
| complementary food | #234 |
| dermatophagoides pteronyssinus | #234 |
| hyperreactive | #234 |
| n144 | #235 |
| fourth grade | #235 |
| resequenced | #236 |
| levels asthma | #236 |
| specific allergen | #236 |
| exposure pregnancy | #236 |
| puberty girls | #238 |
| finland france | #238 |
| strategies prevention | #239 |
| incidence asthma | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| th2 immunity | #243 |
| age exposure | #243 |
| immune development | #243 |
| adaptor protein polymorphism | #245 |
| adjusted odds ratio | #245 |
| receptor 1 | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| nasal microbiota | #247 |
| fever asthma | #247 |
| role development | #247 |
| prick test | #247 |
| patients healthcare | #248 |
| children analysis | #248 |
| factors allergic | #249 |
| class analysis | #249 |
| baseline incidence | #249 |
| therapy severe | #250 |
| clinical science | #250 |
| biological therapy | #251 |
| tlr2 gene | #251 |
| communism | #252 |
| china factors | #253 |
| contact animals | #253 |
| asthma symptoms | #253 |
| cold air | #253 |
| hormonal influences | #254 |
| atopic disease | #255 |
| lowgrade inflammation | #255 |
| preschool dermatitis | #256 |
| h4 acetylation | #256 |
| low pa | #256 |
| human asthma | #257 |
| 454pyrosequencing | #257 |
| adolescent asthma | #257 |
| body mass children | #257 |
| association expression | #258 |
| niaid | #258 |
| epidemiological studies | #259 |
| airborne fungi | #259 |
| prediction quality | #259 |
| exposure early | #260 |
| life asthma | #260 |
| age 6 | #260 |
| 2051 | #260 |
| life symptoms | #260 |
| rhinitis allergic | #260 |
| discriminate | #261 |
| eczema atopic | #261 |
| early life | #261 |
| westernization | #261 |
| interferon expression | #262 |
| spink5 | #262 |
| utilization health services | #262 |
| protein 15 | #263 |
| physician diagnosed | #263 |
| development immune | #263 |
| alpha1antitrypsin | #263 |
| milk pregnancy | #263 |
| children associations | #264 |
| exposure traffic | #265 |
| latex sensitization | #265 |
| indoor exposures | #265 |
| tightly linked | #265 |
| increase asthma | #266 |
| nox concentrations | #266 |
| settled dust | #267 |
| age 13 years | #267 |
| early work | #267 |
| pollen sensitization | #268 |
| rhinitis | #269 |
| fever children | #269 |
| prick | #269 |
| allergen extracts | #270 |
| hypersensitivity immune | #270 |
| symptom prevalence | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| dipeptidyl peptidases | #273 |
| study centres | #273 |
| asthma control patients | #274 |
| objective markers | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| future asthma | #277 |
| male microbiota | #277 |
| dust samples | #277 |
| extracellular polysaccharides | #277 |
| increased exposure | #278 |
| study birth | #279 |
| hire | #280 |
| tests allergens | #280 |
| remedy | #280 |
| questionnaires adolescent | #281 |
| allergies asthma | #282 |
| child dermatitis | #282 |
| 6 years | #282 |
| adolescent animals | #282 |
| randomeffects | #284 |
| collection methods | #284 |
| impulse oscillometry | #284 |
| population burden | #285 |
| 17 children | #285 |
| allergic symptoms | #286 |
| tests respiratory | #287 |
| differences asthma | #287 |
| cells ilc2s | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| hdms | #289 |
| epidemiological surveys | #289 |
| pollution air | #289 |
| risk factors children | #290 |
| role asthma | #290 |
| data normalization | #290 |
| allergic manifestations | #291 |
| asthma increased | #291 |
| asthma factors | #292 |
| eczema food | #292 |
| indoor exposure | #293 |
| answered | #293 |
| cohort participants | #293 |
| environnement | #293 |
| allergic perennial | #293 |
| recruitment domain | #293 |
| longitudinal cohort study | #293 |
| exposure environmental | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| smoke pollution | #297 |
| pollution respiratory | #297 |
| global synthesis | #298 |
| bifidobacterium | #298 |
| unification | #299 |
| exposure allergic | #299 |
| nonatopic | #299 |
| paxgene | #299 |
| obesity asthma | #299 |
| exposure benzene | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| reported association | #307 |
| analysis phase | #307 |
| lumbricoides | #307 |
| antigens dermatophagoides | #308 |
| severe exacerbations | #308 |
| neonatal immune | #309 |
| 2623 | #309 |
| messenger tlymphocytes | #309 |
| mucosal microbiota | #309 |
| ige sensitization | #309 |
| exposure childhood | #309 |
| factors early | #311 |
| controlled asthma | #311 |
| midexpiratory | #312 |
| birth cohort studies | #312 |
| atopic march | #312 |
| asthma inflammatory | #313 |
| allergy age | #313 |
| signal transducer activator | #314 |
| skin examination | #314 |
| bacillus spores | #315 |
| genotyping data | #315 |
| variance animals antigens | #315 |
| jusqu | #315 |
| 2 toll | #316 |
| independent study | #316 |
| older siblings | #317 |
| child comorbidity | #318 |
| pregnancy expression | #318 |
| adjustment covariates | #318 |
| compared children | #319 |
| il5 il13 | #320 |
| fpr2 | #320 |
| bmi united states | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| maximal expiratory | #325 |
| ige responses | #325 |
| stratified sample | #326 |
| 2 yrs | #326 |
| airway hyperresponsiveness ahr | #326 |
| flg mutations | #327 |
| ichthyosis vulgaris | #327 |
| selfadministered questionnaire | #328 |
| active smoking | #328 |
| recurrent wheeze | #328 |
| bedrooms | #328 |
| extracellular dna | #329 |
| glycolylneuraminic | #330 |
| male milk | #330 |
| pollutant levels | #331 |
| demethylation | #331 |
| reference equations | #331 |
| dermatophagoides asthma | #331 |
| floor dust | #331 |
| accuracy analysis | #331 |
| onset asthma | #333 |
| streptococcaceae | #333 |
| asthma biomarkers | #333 |
| reduced lung function | #334 |
| upper respiratory | #334 |
| development sensitization | #334 |
| children controls | #335 |
| boluses | #336 |
| asthma china | #336 |
| risk current | #337 |
| predictive risk factors | #337 |
| 1st year | #337 |
| prevalence surveys | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| respiratory outcomes | #339 |
| risk eczema | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| exposure development | #341 |
| humans prevalence | #341 |
| adultonset asthma | #341 |
| filaggrin gene | #342 |
| persistent wheeze | #342 |
| kitchen | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| stat6 transcription | #346 |
| hypersensitivity | #346 |
| 90th | #348 |
| childhood onset | #349 |
| rates asthma | #350 |
| exposed children | #350 |
| increasing prevalence | #350 |
| prevalence | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| genetic interaction | #359 |
| purposepatients | #359 |
| subsequent asthma | #360 |
| kazal | #360 |
| regression approach | #360 |
| children cohort | #361 |
| eurotium | #361 |
| asthma disease | #361 |
| strength association | #361 |
| expression asthma | #363 |
| cord blood | #363 |
| age 3 | #363 |
| food sensitization | #364 |
| allergic outcomes | #364 |
| farming practices | #364 |
| austria germany | #365 |
| annual concentrations | #365 |
| children reported | #366 |
| chronic inflammatory disorders | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| adolescent air | #370 |
| expression tlr2 | #370 |
| single snp | #370 |
| earlylife exposure | #370 |
| testing procedures | #371 |
| austria switzerland | #371 |
| conclusionwe | #371 |
| 1159 | #371 |
| time activity | #373 |
| obesity prevalence | #373 |
| east west | #373 |
| asthmatic symptoms | #374 |
| 22 countries | #374 |
| asthma current | #374 |
| paragraphs | #374 |
| performance accuracy | #374 |
| smoking asthma | #375 |
| foxp3 tregs | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| positional cloning | #377 |
| associations exposure | #377 |
| cows milk | #377 |
| statistical approaches | #377 |
| mite allergens | #379 |
| population studies | #379 |
| parental reports | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| unifying | #384 |
| preschool cohort studies | #384 |
| measles vaccination | #384 |
| normal lung function | #385 |
| impaired lung function | #386 |
| bronchial | #386 |
| latex | #386 |
| chronic asthma | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| potential association | #391 |
| haplotype analyses | #391 |
| critical window | #391 |
| immunological analysis | #391 |
| 11 year | #392 |
| cde | #393 |
| 14 year | #394 |
| mmp9 gene | #394 |
| early feeding | #394 |
| risk sensitization | #394 |
| polymorphism gene | #395 |
| linear regressions | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| respiratory health | #399 |
| salmeterol xinafoate | #399 |
| study polymorphisms | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| receptor polymorphisms | #402 |
| 2033 | #402 |
| regions countries | #402 |
| length time | #403 |
| analysis asthma | #403 |
| exposure animals | #403 |
| plea | #404 |
| timothy grass | #405 |
| study agreement | #405 |
| allergens | #405 |
| production ifngamma | #406 |
| allergen exposure | #406 |
| cells asthma | #406 |
| 071 | #407 |
| mugwort | #407 |
| childhood allergic | #407 |
| geneenvironment interaction | #409 |
| data cohort | #409 |
| mold exposure | #410 |
| endotoxin exposure | #411 |
| living room | #411 |
| common occurrence | #411 |
| gene variations | #413 |
| blood cb | #413 |
| blood rna | #413 |
| ige synthesis | #414 |
| germany | #415 |
| facemasks | #416 |
| childhood exposure | #416 |
| mite allergen | #416 |
| house dust | #417 |
| illness asthma | #418 |
| 7 years | #418 |
| bronchial hyperresponsiveness | #418 |
| extended haplotypes | #419 |
| population sample | #420 |
| age 2 years | #420 |
| alimentary | #420 |
| prenatal factors | #421 |
| halfwidth | #421 |
| tnc | #424 |
| confers protection | #424 |
| cytokine secretion | #426 |
| parasitic infections | #427 |
| asthma eczema | #427 |
| asthma treatment | #428 |
| duration breastfeeding | #429 |
| childhood eczema | #429 |
| childrens hospitals | #430 |
| tlr1 | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| risk overweight | #433 |
| 441 | #433 |
| specific sensitization | #434 |
| respiratory allergic | #434 |
| age odds ratio | #438 |
| tobit | #438 |
| decrements | #438 |
| allergy diagnosis | #438 |
| conundrum | #440 |
| annual prevalence | #441 |
| asthma gene | #441 |
| population asthma | #442 |
| male odds | #443 |
| fecal microbiota | #443 |
| inception | #443 |
| chronic inflammatory diseases | #443 |
| persisting | #444 |
| asthma effects | #444 |
| cell phenotypes | #444 |
| observed differences | #445 |
| increase bmi | #445 |
| specific serum | #446 |
| asthma respiratory | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| allergy food | #450 |
| 033 | #450 |
| adult asthmatics | #451 |
| associations asthma | #452 |
| n149 | #452 |
| including asthma | #455 |
| school entry | #456 |
| pregnancy increased risk | #457 |
| dermatophagoides farinae | #457 |
| germany health | #458 |
| provocation tests | #460 |
| allergic risk | #460 |
| mice role | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| rural health | #464 |
| asthma higher | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| opposite effects | #467 |
| cells innate | #467 |
| postal questionnaire | #467 |
| alex | #468 |
| severity asthma | #468 |
| immunocap | #468 |
| so2 concentrations | #469 |
| nod1 signaling | #470 |
| early identification | #470 |
| clinical asthma | #470 |
| emphasised | #471 |
| microbial counts | #471 |
| exposure | #471 |
| asthma rhinitis | #471 |
| antibiotics children | #473 |
| fodder | #473 |
| birth cohorts | #473 |
| yrs | #474 |
| 1133 | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| total immunoglobulin | #484 |
| asthma association | #484 |
| subphenotypes | #485 |
| atopic disorders | #486 |
| children | #486 |
| immunity genes | #486 |
| prospective birth cohort | #487 |
| phenotypes | #487 |
| exposure data | #489 |
| potential confounding | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| uncontrolled asthma | #495 |
| polymorphisms association | #495 |
| age 10 | #496 |
| lifestyles | #496 |
| children jia | #497 |
| housing animal | #497 |
| southern germany | #497 |
| phenotype polymorphism | #498 |
| individual level | #498 |
| asthma severe | #498 |
| respiratory hypersensitivity | #500 |
| omega6 fatty acids | #500 |
| birth age | #501 |
| lung function children | #503 |
| asthma susceptibility | #503 |
| sensitizations | #504 |
| diet diversity | #505 |
| tests specific | #505 |
| methods studies | #505 |
| white children | #505 |
| ranks | #508 |
| allergy children | #508 |
| rna samples | #509 |
| childhood respiratory | #509 |
| prevalence rates | #509 |
| housing humans | #510 |
| perennial | #511 |
| stimulation lps | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| asthma prevalence | #515 |
| children exposed | #515 |
| cities china | #516 |
| levels children | #516 |
| receptor tlr | #516 |
| infections asthma | #516 |
| asthma bronchiolitis | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| atopic conditions | #519 |
| th2 immune | #519 |
| haplotype association | #520 |
| eczema asthma | #522 |
| neutrophils eosinophils | #522 |
| risk factors asthma | #523 |
| polymorphisms snps | #523 |
| children maternal | #523 |
| p0041 | #523 |
| age 1 year | #523 |
| time window | #524 |
| rural areas | #524 |
| maternal vitamin | #525 |
| adolescence age | #525 |
| trans fatty acids | #526 |
| baseline participants | #528 |
| bmi increased risk | #528 |
| obesity body mass | #528 |
| 117 95 | #529 |
| c‐reactive protein | #529 |
| blood humans | #529 |
| allergens animals | #529 |
| edifice | #530 |
| persistent asthma | #530 |
| environmental bacteria | #531 |
| obesity smoking | #531 |
| samples children | #532 |
| protect | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| adolescence early adulthood | #541 |
| human microbiota | #541 |
| airway symptoms | #542 |
| immunological markers | #543 |
| lipopolysaccharide receptors | #543 |
| rubella virus | #543 |
| pregnancy asthma | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| antitrypsin alpha | #547 |
| 17q12 | #547 |
| greenness | #548 |
| oligoarticular | #549 |
| floorcoverings | #549 |
| hypersensitivity humans | #550 |
| association children | #553 |
| epidemic proportions | #553 |
| isotype switching | #553 |
| multidisciplinary study | #554 |
| lung microbiome | #554 |
| children parental | #555 |
| mental health patients | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| blood eosinophils | #560 |
| letzten | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| 2 immunity | #566 |
| inhaled steroids | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| tripeptidyl | #570 |
| exposure matrix | #570 |
| initial observations | #570 |
| asthma symptom | #571 |
| health urban | #571 |
| diseases prevalence | #575 |
| hcs patients | #575 |
| levels total | #575 |
| affluence | #575 |
| atopic asthma | #579 |
| creactive protein levels | #579 |
| followups | #580 |
| oro | #580 |
| association obesity | #581 |
| age controls | #581 |
| flanking regions | #582 |
| fdr | #582 |
| asthma population | #582 |
| tlr6 | #584 |
| uht | #584 |
| asthma severity | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| longum | #590 |
| n63 | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| holiday | #593 |
| endotoxin concentrations | #593 |
| il1rl1 | #596 |
| factors respiratory | #596 |
| gasdermin | #596 |
| model asthma | #597 |
| pathogenesis asthma | #598 |
| total specific | #598 |
| advising | #598 |
| zeigen | #598 |
| galactosylation | #600 |
| genetic environmental | #600 |
| active immunity | #601 |
| factors humans | #602 |
| 048 | #603 |
| pregnancy maternal | #603 |
| humans human | #604 |
| statistical analyses | #604 |
| hladqa1 | #604 |
| sensitization | #606 |
| microbes | #606 |
| agents asthma | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| allergic rhinitis | #610 |
| 2 inflammation | #610 |
| infant feeding practices | #611 |
| work life | #612 |
| bolus | #612 |
| 11–13 | #612 |
| regulatory molecules | #612 |
| pollen allergens | #616 |
| aged allergens | #619 |
| chronic stress | #619 |
| albania | #619 |
| urban populations | #620 |
| life age | #621 |
| body plethysmography | #621 |
| arthropod proteins | #621 |
| deep phenotyping | #622 |
| radioallergosorbent | #623 |
| unstimulated | #623 |
| functional features | #625 |
| data prevalence | #627 |
| endotoxin | #627 |
| 779 | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| exacerbating | #635 |
| settled | #635 |
| feeding patterns | #635 |
| child asthma | #636 |
| standardized questionnaire | #637 |
| children atopic dermatitis | #637 |
| lifetime prevalence | #638 |
| igg glycosylation | #639 |
| factors urban | #639 |
| european children | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| kindern | #650 |
| participation rates | #650 |
| pets | #650 |
| health rural | #650 |
| life children | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| dermatitis allergic | #654 |
| comprehensive analysis | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| latent classes | #662 |
| age 1 | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| hygiene | #665 |
| abpa | #665 |
| di2ethylhexyl | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| central european | #672 |
| susceptibility locus | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| protective | #681 |
| female forced | #681 |
| dairy farm | #681 |
| random sample | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| dietary habits | #685 |
| recurrent wheezing | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| sensitization food | #703 |
| hypersensitivity inflammation | #703 |
| microbial flora | #703 |
| risk obesity | #703 |
| tao | #707 |
| dramatic increase | #708 |
| 459 | #708 |
| microbial interactions | #708 |
| perpetuation | #709 |
| immune activation | #709 |
| immunologic tlymphocytes | #712 |
| population surveys | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| alias | #734 |
| 95 males | #734 |
| il4 il13 | #738 |
| linkage chromosome | #741 |
| population adolescent | #741 |
| nonasthmatic | #742 |
| fractional exhaled | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| h20 | #758 |
| environment interactions | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| edn1 | #768 |
| air trapping | #768 |
| hscrp levels | #769 |
| pulmonary function tests | #769 |
| allergists | #769 |
| hyperresponsiveness | #770 |
| blood leukocytes | #770 |
| pattern recognition receptors | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| nucleotide receptors | #773 |
| term impact | #773 |
| incidence longitudinal | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| new associations | #784 |
| studies asthma | #784 |
| children allergic | #785 |
| factors incidence | #785 |
| nonallergic | #788 |
| factors tobacco | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| gis | #793 |
| male metaanalysis | #793 |
| children health | #794 |
| airway hyperresponsiveness | #795 |
| βdiversity | #795 |
| distinct trajectories | #796 |
| natural habitat | #796 |
| personalization | #798 |
| pc20 | #798 |
| protective effects | #799 |
| card15 | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| tenascin | #810 |
| exposure age | #810 |
| bifidobacterium longum | #810 |
| subclinical inflammation | #811 |
| pteronyssinus | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| boiled | #814 |
| initial data | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| studies respiratory | #830 |
| trier | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| rad50 | #833 |
| current analysis | #833 |
| promoter polymorphisms | #834 |
| regularly | #835 |
| igg4 | #835 |
| farinae | #835 |
| snps haplotypes | #835 |
| adolescent age | #837 |
| cx3cr1 | #838 |
| exhaled breath | #838 |
| toll receptors | #839 |
| parental smoking | #839 |
| asthma bronchi | #839 |
| public health problem | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| potted | #849 |
| innate | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| provocation | #856 |
| infant health | #856 |
| infant infant | #858 |
| repeatedly | #861 |
| age 5 | #861 |
| paracetamol | #862 |
| asthma lung | #864 |
| receptors tlrs | #864 |
| questionnaires young adult | #864 |
| volatile organic | #865 |
| birth cohort study | #866 |
| ige | #866 |
| airway eosinophilia | #866 |
| outdoor air pollution | #874 |
| cumulative incidence | #874 |
| latent class analysis | #875 |
| dermatitis | #878 |
| hmos | #878 |
| microbiome humans | #879 |
| 1940 | #880 |
| 057 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| brink | #888 |
| 856 | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| esl | #896 |
| asthma incidence | #896 |
| impact asthma | #900 |
| inflammation airway | #902 |
| immunoglobulin ige | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| shortness | #908 |
| adult asthma | #908 |
| microbiome composition | #910 |
| children overweight | #910 |
| microbiota development | #912 |
| cow milk | #917 |
| complex disease | #917 |
| immunity innate | #919 |
| peripheral blood samples | #920 |
| methods cross | #920 |
| 710 | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| lactococcus lactis | #939 |
| 026 | #939 |
| potential confounders | #940 |
| 13 years | #940 |
| dermatophagoides | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| environmental effects | #952 |
| identification genes | #952 |
| 454 pyrosequencing | #953 |
| solids | #954 |
| 1120 | #954 |
| genotyped | #954 |
| polymorphisms | #954 |
| asthma exercise | #954 |
| human life | #955 |
| infections child | #957 |
| children countries | #959 |
| fever | #959 |
| rhinitis asthma | #961 |
| domestic | #961 |
| exposures | #961 |
| nasal secretions | #964 |
| disease asthma | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| gondii infection | #976 |
| orphan receptor | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| receptor gene | #981 |
| 682 | #981 |
| xinafoate | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| 068 | #991 |
| c3h hej | #991 |
| pasteurization | #991 |
| hercules | #992 |
| function development | #992 |
| asthma humans | #992 |
| design methods | #994 |
| sectional | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| maternally | #1006 |
| rural population | #1006 |
| ppg | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| 039 | #1017 |
| phytohemagglutinin | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| genomewide association | #1033 |
| 096 | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| breastmilk | #1039 |
| dairying | #1039 |
| nod1 | #1042 |
| disease children | #1046 |
| milieu | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| hobbies | #1059 |
| infant gut | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| rural | #1066 |
| predictor | #1066 |
| 8 12 | #1068 |
| skin sensitization | #1068 |
| gnp | #1069 |
| moraxella | #1070 |
| central europe | #1070 |
| margarine | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| large population | #1077 |
| cross sectional study | #1077 |
| box transcription | #1079 |
| west east | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| cells tregs | #1083 |
| study areas | #1083 |
| allergic airway | #1083 |
| children prevalence | #1086 |
| sufferers | #1086 |
| maternal asthma | #1089 |
| lca | #1090 |
| gene expression data | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| nationality | #1096 |
| proteins polymorphism | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| forkhead | #1103 |
| enfants | #1103 |
| studies evidence | #1104 |
| conjunctivitis | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| weight risk | #1116 |
| 248 | #1116 |
| characteristically | #1117 |
| risk gene | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| lung function decline | #1127 |
| sscp analysis | #1127 |
| il12b | #1127 |
| based clustering | #1128 |
| taxonomies | #1130 |
| endotoxins | #1130 |
| expiratory flow | #1132 |
| age birth | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| log2 | #1144 |
| pet ownership | #1144 |
| allergic asthma | #1145 |
| gondii | #1145 |
| pediatric asthma | #1146 |
| patients severe asthma | #1146 |
| 837 | #1152 |
| skewness | #1152 |
| humans respiratory | #1153 |
| environmental tobacco | #1154 |
| regions china | #1154 |
| dust mite | #1156 |
| disease cohort | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| 027 | #1165 |
| anti ige | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| contre | #1184 |
| serum immunoglobulin | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| sedentary lifestyle | #1211 |
| fungi humans | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| risk children | #1218 |
| food hypersensitivity | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| gene variants | #1236 |
| th1 th2 | #1236 |
| age menarche | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| small children | #1243 |
| antitrypsin | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| pertussis | #1252 |
| early years | #1252 |
| peripheral blood leukocytes | #1253 |
| food items | #1253 |
| airway hyperreactivity | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| fev1 forced | #1281 |
| pollution indoor | #1281 |
| children exposure | #1282 |
| shannon | #1284 |
| infections risk | #1284 |
| diseases occupational | #1289 |
| immunomodulating | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| explain | #1303 |
| topic polymorphism | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| lymphocytes regulatory | #1312 |
| factor development | #1312 |
| th1 cytokines | #1314 |
| industrially | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| epidemiological survey | #1322 |
| cell numbers | #1322 |
| harmonization | #1322 |
| objective investigate | #1327 |
| cleaning | #1329 |
| neuraminic | #1329 |
| concerted | #1330 |
| lrti | #1330 |
| prevalence rural | #1331 |
| zusammenfassung | #1331 |
| gambia | #1332 |
| respiratory allergy | #1332 |
| induced sputum | #1335 |
| sponsorship | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| expired | #1353 |
| oxide feno | #1353 |
| irf1 | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| reduction risk | #1358 |
| 16 18 | #1358 |
| asthmatics | #1359 |
| science foundation | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| 279 | #1366 |
| france germany | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| total ige | #1383 |
| common forms | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| risk developing | #1404 |
| severe atopic | #1404 |
| q21 | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| baseline followup | #1417 |
| sige | #1417 |
| immune mechanisms | #1418 |
| bronchodilators | #1418 |
| microbial | #1419 |
| hapmap | #1421 |
| il13 | #1421 |
| bronchitis | #1422 |
| longitudinal cohort | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| asthmatic | #1433 |
| timepoint | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| centres | #1444 |
| inflammatory pathways | #1444 |
| studies europe | #1445 |
| overweight | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| asthma clinical | #1460 |
| agricultural workers | #1460 |
| unique opportunity | #1461 |
| infancy | #1461 |
| immunizations | #1463 |
| 706 | #1464 |
| barcelona | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| surveys questionnaires | #1470 |
| recognition receptors | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| operating characteristics | #1474 |
| leur | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| 1 levels | #1478 |
| innate immune responses | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| peptidases | #1494 |
| strongest predictor | #1494 |
| populationbased cohort | #1504 |
| flexural | #1505 |
| ionomycin | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| sulphur dioxide | #1514 |
| bacterial composition | #1514 |
| ergosterol | #1515 |
| epidemiological data | #1517 |
| moderate asthma | #1517 |
| living environment | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| hladq | #1527 |
| 153 | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| underlying mechanisms | #1536 |
| jia | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| children risk | #1584 |
| licheniformis | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| neuropeptide | #1612 |
| erythrocyte membranes | #1612 |
| peak expiratory | #1613 |
| cells1 | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| cells th2 | #1624 |
| ige antibodies | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| newborn infants | #1641 |
| gata3 | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| topic surveys | #1653 |
| population based study | #1653 |
| style male | #1653 |
| card | #1655 |
| 034 | #1656 |
| microbial diversity | #1656 |
| traffic volume | #1656 |
| smoke exposure | #1657 |
| northern europe | #1661 |
| cells transcription | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| cheese | #1688 |
| epidemiologic evidence | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| innate immune | #1694 |
| obesity risk | #1694 |
| early introduction | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| gene interaction | #1704 |
| phenotyping | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| mere | #1718 |
| house dust mite | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| gabon | #1733 |
| asthma control | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| factors children | #1746 |
| cytokine genes | #1746 |
| 5 7 | #1748 |
| helminth parasites | #1749 |
| inverse relationship | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| male polymorphism | #1756 |
| masks | #1756 |
| fivefold | #1760 |
| gstm1 gstt1 | #1760 |
| refugees | #1761 |
| chronic airway | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| cells airway | #1778 |
| soot | #1778 |
| helminth infections | #1779 |
| occupational exposure | #1782 |
| cd4cd25 | #1782 |
| peptidoglycan | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| key feature | #1801 |
| 054 | #1801 |
| helminths | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| single nucleotide receptors | #1812 |
| treg cells | #1812 |
| feno | #1817 |
| censoring | #1821 |
| protein 3 | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| asthma morbidity | #1828 |
| signal transducer | #1828 |
| respiratory illnesses | #1831 |
| 112 | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| il4 | #1843 |
| regulatory cells | #1843 |
| heterogeneous disease | #1843 |
| fetal growth | #1845 |
| otus | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| unraveling | #1886 |
| diseases lung | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| interleukin5 | #1901 |
| population level | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| vital capacity | #1909 |
| brought | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| experimental models | #1932 |
| basics | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| percentiles | #1946 |
| juvenile idiopathic | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| raised | #1959 |
| moisture | #1959 |
| invading | #1960 |
| blood eosinophil | #1960 |
| asthmatic subjects | #1960 |
| immune mediated | #1960 |
| lps stimulation | #1966 |
| child female | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| agriculture | #2000 |
| descriptions | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| children data | #2020 |
| diary | #2020 |
| regulation genetic | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| bovine milk | #2038 |
| chymase | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| bronchial epithelial cells | #2075 |
| early childhood | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| clinical phenotypes | #2098 |
| abstracts | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| 19th century | #2103 |
| male maternal | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| bacterial colonization | #2111 |
| reduced levels | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| alternata | #2118 |
| prevalence children | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| exhalation | #2145 |
| animals child | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| immune modulation | #2157 |
| schoolchildren | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| west | #2178 |
| stat6 | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| 146 | #2213 |
| communicable | #2213 |
| indoor outdoor | #2215 |
| lung epithelial cells | #2215 |
| onset disease | #2220 |
| early development | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| diesel exhaust | #2242 |
| 12th | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| spirometric | #2247 |
| bacteria fungi | #2247 |
| immune regulation | #2248 |
| whooping | #2249 |
| preventive | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| 108 | #2259 |
| specific immunoglobulin | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| cla | #2282 |
| commensals | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| 064 | #2338 |
| methodsthe | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| expiratory | #2386 |
| immunologically | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| diaries | #2405 |
| bronchodilator agents | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| vitamin intake | #2468 |
| disease review | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| cytokines humans | #2508 |
| children adolescent | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| airway responsiveness | #2525 |
| interleukin13 | #2525 |
| tolllike receptor | #2525 |
| 239 | #2527 |
| common cold | #2528 |
| style | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| inverse | #2553 |
| switzerland | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| suggested | #2584 |
| activator | #2584 |
| myristate | #2585 |
| sectional survey | #2586 |
| disease development | #2586 |
| human microbiome | #2588 |
| 030 | #2590 |
| ω3 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| prenatal exposure | #2638 |
| illness surveys | #2638 |
| translate | #2640 |
| imputation | #2641 |
| molecular patterns | #2641 |
| cb | #2643 |
| 141 | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| exhaled nitric oxide | #2657 |
| virus diseases | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| confounder | #2678 |
| gene expression levels | #2678 |
| girls boys | #2684 |
| urgently | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| host factors | #2699 |
| 061 | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| il23r | #2721 |
| prenatally | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| worldwide | #2739 |
| risk allele | #2739 |
| reaction polymorphism | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| effects air | #2770 |
| species level | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| gstm1 | #2787 |
| messenger receptors | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| tobacco smoke | #2878 |
| deubiquitinating | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| virtually | #2928 |
| male gender | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| patients asthma | #2985 |
| 804 | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| critical period | #2996 |
| year age | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| doubt | #3065 |
| epigenetic mechanisms | #3065 |
| tlrs | #3068 |
| dna extraction | #3069 |
| findings studies | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| adaptive immune responses | #3087 |
| preschool children | #3087 |
| rural area | #3089 |
| rapid increase | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| health surveys | #3257 |
| beds | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| missing data | #3261 |
| systemic inflammation | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| surveys humans | #3318 |
| corynebacterium | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| noncommunicable diseases | #3354 |
| acid receptor | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| protecting | #3409 |
| turn | #3409 |
| alternaria alternata | #3418 |
| tlr | #3421 |
| gg | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| air pollution | #3445 |
| factors smoking | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| 049 | #3468 |
| airflow limitation | #3468 |
| cytokine responses | #3469 |
| omega6 | #3470 |
| th2 cytokine | #3470 |
| rye | #3480 |
| humans linkage | #3484 |
| 043 | #3484 |
| 089 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| postal | #3507 |
| evidences | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| respiratory mucosa | #3525 |
| 032 | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| disequilibrium male | #3686 |
| genetic control | #3686 |
| toxoplasma | #3686 |
| 046 | #3688 |
| adult blood | #3691 |
| monocytogenes | #3691 |
| host immune | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| 456 | #3704 |
| gloves | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| genetic gene | #3735 |
| desorption ionization | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| 094 | #3755 |
| glutathione transferase | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| regressions | #3766 |
| positive bacteria | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| utero | #3873 |
| immunoglobulin | #3873 |
| berlin | #3876 |
| respiratory diseases | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 319 | #3920 |
| 368 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| progeny | #3957 |
| asthma exacerbations | #3957 |
| genetic predisposition | #3958 |
| faced | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| variation humans | #4026 |
| messenger reverse | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| ema | #4036 |
| environments | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| chronic disease | #4118 |
| 052 | #4118 |
| effects exposure | #4120 |
| ethnically | #4120 |
| children 2 | #4126 |
| positional | #4136 |
| 087 | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| mrna expression | #4180 |
| husbandry | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| indoor environments | #4256 |
| participated | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| fluticasone | #4405 |
| age 12 | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| cephalometry | #4418 |
| exposure levels | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| dr3 | #4449 |
| secondary prevention | #4449 |
| receptors protein | #4451 |
| rash | #4457 |
| chances | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| increased prevalence | #4468 |
| respiratory viruses | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| prevalence risk factors | #4499 |
| severe asthma | #4499 |
| culture techniques | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| population prevalence | #4583 |
| ahr | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| haplotypes humans | #4600 |
| adaptor protein | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| respects | #4823 |
| albuterol | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| occupations | #4896 |
| 624 | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| airway disease | #4975 |
| 322 | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| epidemiology | #5018 |
| laser desorption | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| held | #5091 |
| hormonal | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| habits | #5099 |
| unexposed | #5099 |
| 097 | #5100 |
| genomewide significance | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| fingerprinting | #5191 |
| lung epithelial | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| isotype | #5247 |
| bronchopulmonary | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| suppressive | #5348 |
| immunology | #5348 |
| gene expression | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| challenge | #5476 |
| epidemiologic | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| cytokines disease | #5496 |
| floor | #5496 |
| 373 | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| figures | #5602 |
| methacholine | #5602 |
| 258 | #5610 |
| 2nd | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| 081 | #5668 |
| protein coupled | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| offspring | #5704 |
| 134 | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| humans immunity | #5824 |
| comprehensive | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| adjust | #5930 |
| encourage | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| investigate association | #5947 |
| questionnaire survey | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| 367 | #6008 |
| patients symptoms | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| adult population | #6032 |
| obese children | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| ors | #6082 |
| unselected | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| conferred | #6117 |
| recruiting | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| populations | #6233 |
| genuine | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| administration inhalation | #6246 |
| prematurity | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| study groups | #6270 |
| indoor environment | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| allele frequencies | #6326 |
| infrequent | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| adverse health | #6475 |
| lower respiratory | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| gst | #6507 |
| sleep disturbance | #6507 |
| 238 | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| 283 | #6602 |
| disease onset | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| impulse | #6732 |
| haplotypes | #6732 |
| 0009 | #6734 |
| cells disease | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| growing | #6846 |
| elucidated | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| lung | #6972 |
| pathogenic bacteria | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| linoleic acid | #7111 |
| type 1 diabetes | #7111 |
| triggering | #7114 |
| serum total | #7117 |
| breath tests | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| agents anti | #7184 |
| likewise | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| influences | #7244 |
| beta1 | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| herpesviridae | #7299 |
| urbanization | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| alps | #7515 |
| spp | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| overt | #7613 |
| diseases animals | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| peanut | #7684 |
| prenatal | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| lockdown | #7950 |
| prevalence incidence | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| determinants | #8119 |
| regarded | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| genera | #8357 |
| nineteen | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| syncytial | #8462 |
| anhydride | #8462 |
| contrasting | #8463 |
| similarities | #8478 |
| minor | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| cesarean | #8884 |
| burden disease | #8884 |
| ears | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| multivariate analyses | #9269 |
| popularity | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| allele frequency | #9306 |
| haplotype | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| olds | #9364 |
| responders | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| crude | #9672 |
| dietary supplements | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| diagnoses | #9743 |
| common genetic | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| directly | #9772 |
| publications | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| 102 | #9849 |
| cluster | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| 1991 | #9964 |
| bacterial infections | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| 4 months | #10169 |
| exclusions | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| interleukin12 | #10361 |
| factorial | #10361 |
| 142 | #10364 |
| concepts | #10386 |
| centrally | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| female gastrointestinal | #10776 |
| regulation humans | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| low birth | #11092 |
| serology | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| gram negative | #11824 |
| 222 | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| european | #12469 |
| inflammatory cytokine | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| scarce | #12583 |
| 17 years | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| infants | #12943 |
| elevated levels | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| 52 | #13056 |
| annually | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| future | #13086 |
| suffer | #13086 |
| genetic rna | #13096 |
| glucocorticoids humans | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| cohorts | #13856 |
| concerns | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| feces | #15556 |
| 003 | #15556 |
| dysregulation | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 91 | #16918 |
| 09 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| earlier | #17361 |
| drug therapy | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| sum | #18807 |
| candidate | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| 1997 | #18843 |
| basis | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| mouse model | #19415 |
| trait loci | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| inbred balb mice | #19855 |
| 1998 | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| context | #19977 |
| baseline | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
Rapport d'exécution | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| Connu pour Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| Connu pour International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| Connu pour Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| Connu pour Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| Connu pour Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| Connu pour Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| Connu pour Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| Connu pour European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| Connu pour Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| Connu pour East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| Connu pour International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| Connu pour Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| Connu pour Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
Des personnes clés pour Atopic Dermatitis
Top Kols dans le monde
Sélectionnez une phrase de recherche atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:Impact expert
Concepts pour lesquelsErika RM von Mutiusa une influence directe:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:Impact de Kol
Concepts liés au travail d'autres auteurs pour lesquelsfor which Erika RM von Mutius a une influence:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
Est-ce votre profil? Réclamez votre profil Copier le lien ENCHED LIEN À VOTRE PROFIL |